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 Cataract, the opacification of an eye lens, is a common pathological abnormality 
of the lens accounting for approximately 50% of all blindness. The only effective 
treatment currently available for a cataract is the surgical removal of the affected lens and 
replacement with an artificial lens for the restoration of vision. Although, cataract surgery 
is considered to be a very successful procedure in terms of visual outcome, the cost of 
surgery, need for trained personnel and surgeons, and postsurgical complications, limit 
the worldwide availability and accessibility of this procedure. Hence, alternative 
preventive and treatment procedures are worthy of investigation. The lens depends on a 
balanced redox state for maintaining its transparency, and a high content of glutathione 
(GSH) in the lens is believed to play a key role in doing so. Several studies have reported 
that oxidative stress plays an important role in the etiology of cataract development and, 
therefore, the present study has sought to evaluate the efficacy of a thiol antioxidant, (R) -
N-acetylcysteine amide (NACA), in preventing/reversing cataracts. To investigate 
NACA’s ability to provide therapeutic benefits for cataracts, three different experimental 
models were utilized. The first was an ex-vivo cataract model, where culturing the rat 
lenses in dexamethasone resulted in posterior cataracts. The second was an in vivo mouse 
model, where injection of acetaminophen caused cataracts. The third model was a rat in 
vivo model where injection of sodium selenite generated nuclear cataracts. Treatment 
with NACA in each model helped to decrease the severity of cataracts. In summary, the 
results from this study suggest that NACA can potentially be developed into a promising 
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 A cataract causes a progressive loss of transparency of the lens that affects vision. 
It is the most common cause of curable blindness, which accounts for approximately 50% 
of all blindness. Thus more than 17 million people are blind because of cataracts, and 
worldwide, 28 000 new cases are reported daily. Most cataracts are age related and, 
according to the National Eye Institute (NEI), by age 80, more than half of all Americans 
either have a cataract or have had cataract surgery. In the U.S. over 1.2 million cataract 
operations are performed per year; the costs are over 3.4 billion dollars [1]. The NEI and 
Prevent Blindness America estimate that more than 22 million people in the U.S. live 
with cataracts and, by 2020, this may exceed 30 million (NEI, 2008) [2]. Although, a 
cataract is not associated with signs such as pain or redness in the eye, it is still 
characterized by symptoms such as blurry vision, double vision, glare of light, and 
yellowing of colors. The only effective treatment currently available for a cataract is the 
surgical removal of the affected lens and replacement with an artificial lens for the 
restoration of vision. However, the cost of surgery and requirements for highly trained 
personnel to perform ocular surgery, limit the restoration of vision in certain parts of the 
world. Unfortunately, a majority of people with vision impaired by cataracts live in 
developing countries where access to surgery is limited [3]. Hence, there is an immediate 
necessity for prevention and non-invasive treatment of cataracts. 
 The lens is a transparent, biconvex, avascular structure that is responsible for 
focusing the images onto the retina [4]. The lens depends on a balanced redox state to 





stress requiring elevated levels of cellular antioxidants to neutralize reactive oxygen 
species (ROS). The endogenous high level of glutathione (GSH) is responsible for the 
first line of defense against oxidative stress and keeps lens proteins in a reduced state, 
thereby, maintaining lens transparency [5]. During the development stage of the lens, it 
has been determined that it contains a high concentration of antioxidant enzymes, as well 
as GSH. However, with aging, the de novo synthesis and the recycling system for GSH 
become less efficient [6],  causing diminished levels of GSH and other antioxidant 
defenses. This leads to increased incidences of oxidative damage, which eventually 
results in the formation of cataracts. 
 Cataractogenesis is considered to be a multifactorial disease involving various 
pathogenic mechanisms that are not clearly understood, with oxidative stress being the 
foremost cause in initiating cataract formation [7-13].  Oxidative stress implies an 
imbalance between the rate of oxidant production and the rate of detoxification, with the 
rate of production being significantly higher when compared to that of detoxification by 
antioxidants [14]. An organism counteracts this condition by its natural antioxidant 
defense systems, but with age, oxidants accumulate while antioxidant defenses gradually 
diminish. This could probably be the most important mechanism in age-related cataract 
formation. Accumulation of oxidants results in aggregation and precipitation of crystallin 
proteins, which are responsible for maintaining transparency of the lens [15]. Since 
crystallins make up more than 90% of the total dry mass of the lens, aggregation and 
precipitation of these proteins leads to insolubility and fragmentation, eventually 





 Since oxidative stress is implicated in cataract formation, a logical approach to 
counteract cataractogenesis would be the use of an effective lens permeating antioxidant 
that would neutralize and alleviate cumulative oxidative damage. Several compounds 
with antioxidant properties have been reported to prevent cataracts, with few of them in 
the clinical phase. One such powerful antioxidant, which was recently developed into an 
eye drop formulation, is N-acetylcarnosine. The topical administration of N-
acetylcarnosine (as a bio-activating antioxidant for vision) in an eye drop formulation 
delivered pure L-carnosine, which was found to be present in appreciable levels in 
transparent human lenses and depleted in the lenses of mature cataracts [17]. This 
allowed an increased intraocular absorption of L-carnosine resulting in an increased anti-
cataract drug efficacy [18]. Although recently published studies have reported that N-
acetylcarnosine may ameliorate the risk for cataracts [18], a larger trial was needed to 
justify the long-term benefit of N-acetylcarnosine. 
 Use of antioxidants to treat/prevent oxidative stress-related disorders is becoming 
more popular, with thiol antioxidants (such as GSH, cysteine, and N-acetylcysteine 
(NAC)) providing some protection [19-21]. However, NAC is negatively charged at 
physiological pH, which limits its ability to permeate cell membranes and, therefore, 
requires higher doses and longer times of treatment. In contrast, N-acetylcysteine amide 
(NACA), an analog of NAC, has been shown to be more effective than NAC, owing to its 
neutral amide group, making it more lipophilic and, therefore, increasing its ability to 
penetrate cell membranes. Previous studies have also shown that NACA is lipophilic and 
can cross membranes, chelate Cu2+, scavenge free-radicals, and protect against oxidative 




alleviating oxidative stress [26, 30]. Furthermore, NACA is effective at lower 
concentrations (compared with NAC), which helps to prevent the various adverse effects 
that are associated with administration of higher doses of NAC [19, 24, 31-33].  
 The development of an antioxidant eye drop formulation that could prevent and 
reverse the cataract grade would significantly reduce the number of patients becoming 
blind worldwide because of the unavailability of surgical procedural treatments and also 
because of the financial burden involved in undergoing cataract surgery. By slowing the 
onset of cataract formation, or arresting the progression of the disease in its early stages, 
surgery could be completely avoided in many cases. Therefore, the present study has 
sought to evaluate the efficacy of the thiol antioxidant, NACA, in preventing/reversing 
cataracts in rodent models. A successful result of this research would provide impetus for 
further study of antioxidant-based approaches in treating cataracts, with the emphasis 
shifted towards a mechanistic approach rather than surgical intervention, which would be 











 A cataract is an opacification of the lens of the eye affecting the vision. The lens 
is a transparent, biconvex, elliptical, semi-solid, avascular structure that is located 
between the iris and the vitreous (Figure 2.1). The lens, along with the cornea, focuses 
light onto the retina, the light-sensitive tissue at the back of the eye. To do this, the lens 
must be clear, have a relatively high refractive index, and be able to accommodate. The 
cloudiness in the lens scatters the light before arriving at the retina, hence the image 




   
Figure 2.1. Eye. Diagrammatic representation of adult human eye showing the location of 




 In the embryonic stage, the lens appears as a hollow ball of cells surrounded by a 
capsule, with each cell containing a nucleus. The outside facing surface of the eye is 
designated as the anterior side of the lens and the inside facing surface is designated as 
the posterior side. As the lens develop, the posterior cells elongate into the cavity towards 
the anterior cell layer forming the primary lens fiber which forms the core of the lens 
nucleus [34, 35]. During this process, the cells also make a large quantity of proteins 
called crystallins which becomes the primary structural components of the lens fiber. The 
primary lens fibers soon lose their nuclei and other cellular organelles and become inert 
structures. However, the anterior cells remain in the lens as a single layer of living cells 
along the anterior surface and will continue to divide along the edges to form secondary 
lens fibers which form the core of the lens cortex. As the secondary fibers grow, they also 
make large quantities of crystallins; however, at maturation, they lose their nuclei and 
other cellular organelles resulting in the loss of ability to synthesize crystallins [36, 37]. 
New secondary lens fibers continue to form throughout the life of a person (Figure 2.2). 
 The primary structural proteins of the lens fiber cells that are responsible for the 
lens transparency and uniform refractive index, and for maintaining minimal light 
scattering are crystallins. The crystallins constitute more than 90% of the total dry mass 
of the lens. Crystallins are water soluble lens proteins which cannot be replaced and, thus, 
have to last the lifetime of an organism. Most of the vertebrate lenses contain three 
classes of crystallins- the α-, β-, and γ-crystallins. In the lens under 15 years of age, 
nearly 50% of the nuclear soluble protein is α-crystallin. By their mid-20’s, this drops to 
25% and by the mid-40’s, α-crystallins represent less than 5% of water-soluble lens 








Figure 2.2. Lens Structure. This figure shows a cross section of the entire structure of a 
lens that has been divided into various regions. The anterior region of the lens capsule is 
surrounded by epithelial cells. The bow region is where cells differentiate, elongate, lose 
their organelles, and mature into fiber cells. 





 In addition, with time, these crystallins undergo several irreversible changes 
because of proteolysis, oxidation, deamidation, maillard reactions, and cleavage resulting 
in protein insolubilization and precipitation [40-45].  With aging, the antioxidant defense 




efficiencies associated with GSH, resulting in the accumulation of crystallin proteins. The 
cumulative effects of the above ultimately leads to a cataract. 
 While the etiology of cataracts is still unclear, oxidation is considered as the 
major cause of cataract formation [5, 46-48]. Crystallin proteins contain amino acids 
(such as cysteine and methionine) which are prone to oxidation. While α-crystallin has 
only two cysteine residues, β-crystallin has several cysteine residues that are susceptible 
to oxidation, making intra-disulfide linkages more probable, resulting in high molecular 
weight aggregates. Tryptophan and histidine are susceptible to oxidation, but their 
oxidation in aging lenses is minimal, as compared to that of cysteine, although an 
evidence has been shown that these amino acids are oxidized in advanced cataract 
development [5]. Free radicals, such as hydroxyl radical, superoxide, and singlet oxygen, 
are the likely oxidizing species in vivo [49-52]. The α-crystallin binds to early unfolding 
intermediates of other crystallins, preventing their aggregation and insolubilization and 
hence, preventing light scattering [40]. Investigators have suggested that once all of the  
α-crystallin has been utilized, the concentration of the irreversibly denatured proteins 
would rise to a level at which aggregation occurs, resulting in a cataract [40]. Crystallin 
proteins cannot be replaced and, with aging, these proteins accumulate at the center of the 
lens. Since these proteins cannot be repaired nor catabolized, having a protein that has 
chaperon-like characteristics would be beneficial to the eye lens. The chaperon-like 
activity of α-crystallins may be the reason why these proteins were recruited by the eye 
[15]. Investigators have shown that non enzymatic glycation, truncation and oxidation of 
α-crystallins results in the loss of chaperon activity [53, 54]. There are two α-crystallin 




identity [55]. In the mammalian lens, the molar ratio of αA to αB is generally three to one 
[40]. The αA crystallin is mainly expressed in lens, with trace amounts found in other 
tissues [56-58]. The αB crystallin is considered ubiquitous and is expressed abundantly in 
the brain, heart, and muscle [59]. Since crystallins have to last the lifetime of an 
organism, they are susceptible to the accumulation of various post-translational 
modifications that are thought to damage their structure and alter the function of 
crystallins [60-62] . The crystallin proteins of the lens have several phosphorylation sites 
that have been shown to regulate the chaperone activity of α-crystallin proteins [63-65]. 
Phosphorylation at serine residues 19, 45, and 59 have been identified as a major 
modification for α-crystallins [66]. Despite phosphorylation being a common feature of 
α-crystallin, both inside and outside the lens [67], the in vivo significance of these 
modifications and their effects on chaperone-like activity remain unclear [55]. Many 
researchers have reported that phosphorylation has no effect on chaperone activity [68, 
69], but one study demonstrated that a sub-unit of α-crystallin protein from a cataract lens 
was not phosphorylated [70]. The significance of this absence of phosphorylated α-
crystallin is yet to be determined. S-Methylation, that is specific for Cys 26 and Cys 24, 
is one of the most prominent post-translational modifications of human lens crystallins. 
In contrast to most post-translational modifications, which continue to increase with lens 
age, methylation levels reach to 40% at about 19 years of age, increase further to 50%, 
and then decrease slightly as the lens gets older. Methylation of these exposed cysteine 
residues prevents their participation in the intermolecular disulfide bonding that leads to 
protein cross linking, aggregation and, eventually, cataracts. Hence, methylation could be 




2.2. OXIDATIVE STRESS 
 The lens depends on a balanced redox state for maintaining its transparency, and a 
high content of GSH in the lens is believed to play a key role in doing so. Alterations in 
the GSH metabolism within the lens result in an increased oxidative stress that has been 
implicated in the pathogenesis of a cataract [10, 48]. As the lens age, the oxidants (ROS) 
accumulate as a result of oxidative stress, causing damage to the eye. The lens defends 
this condition by employing antioxidant enzymes and proteins which help in protecting 
important biochemical functions within the eye. ROS, such as superoxide radical, 
hydrogen peroxide, and hydroxyl radical, attacks the proteins and polyunsaturated fatty 
acids (PUFAs) of lipid membranes causing damage to the eye. UV light also generates 
oxidative stress and the eye is more susceptible to UV damage as the lens age. The levels 
of UV filters in the lens decrease linearly with age, at a rate of 12% per decade [74]. 
 2.2.1. Reactive Oxygen Species (ROS). Highly reactive biochemical compounds 
containing oxygen are collectively known as ROS. Most ROS are generated as by-
products during mitochondrial electron transport of aerobic respiration or by 
oxidoreductase enzymes and metal catalyzed oxidation [75-82]. It was originally thought 
that only phagocytic cells produce ROS as a part of their host cell defense mechanism. 
Recent studies have demonstrated that ROS have a role in cell signaling, including 
apoptosis, gene expression, and the activation of cell signaling cascades [83]. However, 
during times of environmental stress, such as UV or heat exposure, ROS levels, that can 
increase dramatically [84], have the potential to cause a number of deleterious events. 
There are numerous types of ROS; however, those which are also free radicals are the 





•−), hydroxyl radical (OH•), and hydrogen peroxide (H2O2). 
Although H2O2 is not a free radical by itself, via Fenton reaction it generates OH
• radical 
which is the most reactive free radical. Because of the presence of unpaired valence 
electrons, these species are highly reactive and can damage cellular structures. 
 2.2.2. Lipid Peroxidation (LPO). This is a process under which free radicals 
attack lipids containing carbon-carbon double bonds, especially PUFAs that involve 
abstraction of hydrogen from a carbon, with an oxygen insertion leading to lipid peroxyl 
radicals and hydroperoxides[85]. Glycolipids, phospholipids, and cholesterol are the most 
susceptible lipid structures that promote free radical attack. LPO produces a wide variety 
of oxidation products. Lipid hydroperoxides (LOOH) are the primary products of LPO. 
Among different aldehydes that are produced as secondary products, malondialdehyde 
(MDA), hexanal, and 4-hydroxynonenal (4-HNE) have been extensively studied [86-97]. 
These lipid by-products are formed via a free radical chain reaction that occurs within the 
cellular environment. MDA is considered to the most mutagenic by-products of LPO, 
whereas 4-HNE is the most toxic. The mechanism of LPO is shown in Figure 2.3.  
 Initiation of LPO begins with the abstraction of hydrogen by a hydroxyl radical 
from the methylene group, adjacent to a double bond of PUFAs, leading to an unstable 
lipid radical. This leaves an unpaired electron on the carbon, forming a carbon-centered 
radical, which is stabilized by a molecular rearrangement of the double bonds to form a 
conjugated diene, which then readily reacts with oxygen to form a peroxyl radical. The 
lipid radical or the peroxyl radicals can abstract hydrogen from the neighboring fatty acyl 
chain of PUFAs, thereby leading to the propagation of the peroxidation process and a 




terminates with the formation of LOOH. The LOOH is the first, comparatively stable 
product of lipid peroxidation [99]. Lipid peroxidation causes injury to cells and 
intracellular membranes which can lead to cell destruction and, subsequently, cell death 
[100]. The LOOH reacts with transition metal ions, leading to the generation of radicals 






Figure 2.3. Lipid Peroxidation. Chain of events in lipid peroxidation, starting with 
initiation, propagation and termination stages.  
(Illustration: Vikram Jairam, Koji Uchida, and Vasanthy Narayanaswami. 




 2.2.3. Protein Oxidation. Protein oxidation involves a number of modifications 
including hydroxylation of amino acids, such as tyrosine, phenylalanine, oxidation of 
methionine to methionine sulfoxide, and oxidation of cysteine residues to disulfides. The 
thiols in the cysteine residues of proteins may undergo different reversible and 
irreversible redox modifications in reaction with ROS and reactive nitrogen species 
(RNS) that are considered to be important for protein regulation. However, most of these 
modifications are readily reversible through mechanisms involving GSH. ROS and RNS 
can oxidize proteins in different pathways. RNS can cause S-Nitrosylation of the thiol 
residues of proteins, whereas oxidants (like H2O2) oxidize thiols to sulfenic acid, sulfinic 
acid, and sulfonic acid. Although sulfenic acid is readily reversible by GSH, because of 
its instability it undergoes further oxidation to sulfinic and sulfonic acids, which cannot 
be reversed by GSH. In the presence of ROS or RNS, a cysteine residue forms a thiol 
radical which then reacts with another thiol radical of the vicinal or neighboring protein 
resulting in protein disulfides. The mechanism of protein oxidation is shown in Figure 
2.4. 
 
2.3. ANTIOXIDANT DEFENSE 
 The human body has employed different antioxidants to counterbalance the 
oxidative stress caused by various oxidants. Sies [103] stated antioxidant as ‘any 
substance that, when present at low concentrations compared  to that  of  an oxidizable  
substrate, significantly delays  or  inhibits  oxidation  of  that  substrate’. Antioxidants acts 
as a first line of defense against ROS formation. These can be classified into two 
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Figure 2.4. Modification of Protein Thiols. Protein thiols undergo different modifications 
after reactions with ROS and RNS. NO• reacts with the protein thiols causing S-
Nitrosylation. Glutathione disulfide (GSSG) undergoes disulfide exchange with protein 
thiols resulting in S-Glutathionylation. Oxidation of thiols in the presence of ROS (such 
as H2O2) leads to sulfenic acid, which can then be oxidized to sulfinic acid and sulfonic 
acid. In the presence of ROS, a cysteine residue forms a thiol radical which then reacts 
with another thiol group to form a disulfide bond.  
 
 
Table 2.3. Classification of Antioxidant Defense Network 
Antioxidant Enzymes Small antioxidants  
Superoxide dismutase  
Catalase 
Glutathione peroxidase  
























 2.3.1. Antioxidant Enzymes. The eye contains several antioxidant enzymes that 
play key role in protecting the eye against oxidative damage. The important enzymes 
include superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, 
thioltransferase, and thioredoxin. 
 Superoxide dismutase (SOD) is an enzyme that catalyzes the dismutation of 
superoxide to hydrogen peroxide and molecular oxygen [104].  
                    O2
•− + O2
•− + 2H+                               H2O2 + O2    (Reaction 1)     
 The antioxidant system of SOD is formed by three isoenzymes, with CuZn-SOD 
existing in cytosol [105], Mn-SOD in the mitochondrial matrix [106], and secretory EC-
SOD in the tissue interstitium [107]. A large difference in the total amount of SOD 
activity and isoenzymes distribution in different compartments of the human eye have 
been reported [108], with the retina having the highest activity of SOD and the lens 
having the least SOD activity of any mammalian tissue examined so far [109]. CuZn-
SOD isoenzyme activity per milligram of DNA was found to be highest in the retina, 
when compared to most other extraocular tissues. EC-SOD activity was reported to be 
highest in the sclera and cornea which accounts for more than half of the total SOD 
activity in these tissues [108]. 
 The aqueous humor of many species (including human eye) has been shown to 
contain significant amounts of H2O2 [110-112], which may be formed from the light 
catalyzed reaction of ascorbic acid that is present in the aqueous humor [111, 112]. H2O2 
is also formed from the dismutation of superoxide by SOD. H2O2 accumulation, if not 
counteracted, could lead to severe oxidative damage resulting in the loss of cell function 




glutathione peroxidase (GPx) enzymes, that can counteract the H2O2 that is generated in 
the eye. Catalase catalyzes the degradation of hydrogen peroxide to water and oxygen 
[116] (Reaction 2). However, GPx also detoxifies the H2O2 using GSH as a substrate 
(Reaction 3). Relative activities of catalase and GPx suggest that GPx is more significant 
in detoxifying the peroxide at low concentrations[117, 118], whereas, at concentrations 
exceeding the physiological limit, catalase becomes more important [119, 120]. Also, in 
contrast to catalase, GPx can use substrates other than H2O2 such as hydroperoxides 
which serve as substrates for the metal catalyzed Fenton reaction that generates highly 
reactive hydroxyl radicals.           
                                      2H2O2                               2H2O + O2  (Reaction 2) 
         2GSH + 2H2O2                                GSSG + 2H2O      (Reaction 3) 
 Glutathione reductase (GR) is an enzyme that catalyzes the reduction of GSSG to 
GSH in the presence of NADPH as an electron source [121-123] (Reaction 4). 
   GSSG + NADPH                     2GSH + NADP+ (Reaction 4) 
Thioltransferase (Ttase), also called glutaredoxin, catalyzes the reversible thiol-
disulfide exchange reactions in the presence of GSH. The whole reaction system plays a 
key role in maintaining the thiol/disulfide ratio in the cell [124-126] (Reaction 5-7). The 
standard spectrophotometric analysis of Ttase depends on coupling the formation of 
GSSG and its reduction by GR in the presence of NADPH. 
  PS-SP + GSH                       P-SH + P-SSG (Reaction 5) 
  P-SSG + GSH                      P-SH + GSSG (Reaction 6) 










 Thioredoxin (Trx) system is the major ubiquitous disulfide reductase system with 
two redox-active cysteine residues, -Cys-Gly-Pro-Cys-, in its active site [127]. It is 
responsible for maintaining proteins in their reduced state with the help of NADPH and 
Trx reductase [128]. The cysteine residues are used by Trxs to catalyze the breakage of 
protein thiol disulfide bonds. Upon completion of one cycle, these two cysteine residues 
are oxidized resulting in a disulfide bond.  Thioredoxin reductase (Trx reductase) 
converts these oxidized cysteine residues to their native reduced form with the help of 
NADPH [129] (Reaction 8). 
 
           PS-SP + Trx-(SH)2                                         2P-SH + Trx-S2  (Reaction 8) 
                                                                       
                                                                                 
  
 
 2.3.2. Small Antioxidants. Antioxidant proteins, along with antioxidant enzymes, 
form the first line of defense against oxidants that are generated during oxidative stress. 
They play an important role in maintaining cellular functions and have been implicated in 
processes associated with aging, cancer, diabetes, and several brain disorders. Among 
these small antioxidants that are mentioned in table 2.3, GSH is the most important one. 
 Glutathione (γ-L-glutamyl-L-cysteinyl-glycine, GSH) is the major low molecular 
mass protein thiol that is found in cells of plants and animals [130]. It is a tripeptide 
containing the amino acids glutamate, cysteine, and glycine (Figure 2.5). The cysteine 
associated with the GSH is non-toxic [131], and the thiol group in the cysteine gives 
NADPH NADP+ 




antioxidant properties to the GSH which promote for its cellular defenses against 
oxidative stress [132].The unusual γ-linkage between glutamate and cysteine is thought to 
prevent the GSH from being degraded by aminopeptidases, resulting to its high stability 




Figure 2.5. Structure of Glutathione. 
 
 
 GSH is synthesized in the cytosol in two steps that require ATP. The first step 
involves the formation of γ-glutamylcysteine in the presence of enzyme γ-
glutamylcysteine synthetase (γ-GCS). This step in the synthesis is the rate limiting step. 
The next step is the formation of GSH by glutathione synthetase (GS), which utilizes γ-
glutamylcysteine and glycine as substrates (Reaction 9) (Figure 2.6). 
 
 
Glu + Cys                             γ-glu-cys                            γ-glu-cys-gly (GSH) 






 The lens contains a very high concentration of GSH which serves to protect the 
protein thiols from oxidation to disulfides and, hence, is essential for maintaining the 
transparency of the tissue [133]. The turnover rate of GSH in the lens was found to be 
very high, with the compound completely broken down and resynthesized in the tissue 
about every 48 h [134]. However, the concentration of GSH decreases steadily with age 
due to the accumulation of oxidants that result from the decreased levels of antioxidant 
enzymes required for GSH turnover[135]. The γ-GCS (rate limiting enzyme in GSH 
synthesis) activity in old people falls to one sixteenth of the value found in young ones 
[136]. With the decreased GSH synthesis, the protein disulfide accumulates causing 
protein aggregation, insolubilization, and precipitation[137]. This may be an important 
factor in age-related cataractogenesis [138]. 
 Ascorbic acid (Vitamin C) is a water soluble vitamin that scavenges oxygen free 
radicals, thereby providing antioxidant capacity. It helps to regenerate Vitamin E (α-
tocopherol) that gets oxidized in the presence of lipid peroxidation (Figure 2.7). With 
age, the plasma levels of Vitamin C have been shown to decrease [139, 140]. 
 The water soluble vitamin, α-Tocopherol (Vitamin E), which is present in the 
interior of a cell membrane, is the primary antioxidant against oxidant-induced membrane 
damage. It donates electrons to peroxyl radicals that are generated during lipid 
peroxidation. α-Tocopherol was shown to prevent pro-inflammatory cytokines, such as 
IL-1 and IL-6, resulting in protection against myocardial ischemic reperfusion [141]. 
It was also reported that Vitamin E triggers apoptosis of cancer cells and inhibits free 
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Figure 2.6. Schematic representation of Antioxidant Defense Network. Scheme depicting 
the basic reactions that take place after the generation of superoxide (O2
•−) radicals, and 
activation of antioxidants to counterbalance the ROS. γ-Glutamylcysteine synthetase (γ-
GCS); GSH synthetase (GS); GSH peroxidase (GPx); Thioltransferase (Ttase); GSSG 
reductase (GR); Glucose-6-phosphate dehydrogenase (G6PD); Glucose-6-phosphate 
(G6P); 6-phosphogluconate (6PG); Protein thiol disulfides (PSSP); Protein mixed 




2.4. CALPAIN ACTIVATION  
 Calpains (Figure 2.8) are cysteine proteases that are found in cytosol whose 
enzyme activity depends on calcium (Ca2+). They perform various functions in biological 
processes, such as signal transduction, cell proliferation, cell cycle progression, 
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 Over activation of calpain was found to be implicated in muscular dystrophy, 
cardiac and cerebral ischemia, platelet aggregation, neurodegenerative diseases, 






Figure 2.7. Antioxidant Regeneration System. 





 The calpain superfamily contains at least 12 different calpain members of which 
µ-calpain and m-calpain are the best characterized ones. However, both of these proteins 
differ in the sensitivities they have toward calcium. For example, µ-calpain is highly 
sensitive to calcium, even at lower concentrations (5-50 µM), whereas m-calpain has low 
sensitivity to Ca2+, requiring high concentrations (200-100 µM). Both µ-calpain and m-
calpain are heterodimers with a large78-80 kDa catalytic subunit and a small 28kDa 
regulatory subunit. The large subunit involves four domains (dI-dIV), whereas the small 





Figure 2.8. Human m-Calpain Crystallographic Structure. The domains are colored 
differently and are labelled as dI, dII, dIII, dIV, dV, and dVI. The active site Cys, C105 is 
shown in gray as are His-262, Asn-286, and Trp-288 on domain IIb. (Adapted from 





 Domain I consists of α-helix anchored in a cavity of dVI, which stabilizes the 
circular arrangement of calpain. Domain II consists a catalytic site, which can be divided 
into two, dIIa and dIIb. Domain III contains an acidic loop that plays a role in Ca2+-
promoted activation of calpain [150, 151]. Domains IV and VI are calcium-binding 
domains with each containing five EF- hand motifs similar to calmodulin protein. Hence, 
domain dVI is often termed as the calmodulin-like domain [152]. Domain V is 




 Calpain exists as an inactive proenzyme in the cytosol which, in response to 
increased Ca2+ levels, gets translocated to the membrane, where it undergoes activation in 
the presence of Ca2+. In the absence of Ca2+, the sub-domains of domain II (dIIa and dIIb) 
remain separated due to structural constraints. The activation of calpain is a prerequisite 
to release the constraints and formation of a functional catalytic site [150, 151, 153, 154]. 
Activation of m-calpain involves two stages, as shown in Figure 2.9 [153-156]. The first 
stage is the release of structural constraints imposed by domain interactions. Calcium 
binding to domains IV, VI, and III releases domain I from domain VI, and domain II 
from domain III, leading to the dissociation of 28kDa subunit from 78kDa subunit. The 
second stage involves conformational changes in domain II, which is a consequence of 
Ca2+ binding to the acidic loop in dIII, resulting in the two sub-domains (dIIa and dIIb) 
come closer to form a catalytic site of the enzyme [150, 157]. However, the 
rearrangement of the sub-domains of domain dII can occur only after the release of 
constraints from the first stage [153].  
 In summary, with increased intracellular calcium levels, the salt bridge 
interactions unfold (i.e., activation, also called autolysis) releasing the constraints of 
domain interaction that lead to the dissociation of the smaller subunit from the larger one. 
This is followed by the rearrangement of domain II, resulting in the formation of a 
catalytic site and, ultimately, activation of the enzyme that hydrolyzes the structural 
proteins of the lens. The autolysis (initial activation) of calpain requires high 
concentrations of intracellular Ca2+, which physiologically is not possible as calcium 
never reaches the range required for the activation. Thus, there may be other biological 




phospholipids [159, 160], such as phosphatidylinositol (that increases calpain sensitivity 
to Ca2+ by ten-fold), and activator proteins [161, 162] (that increase the sensitivity by 
hundred-fold). With involvement of these factors, autolysis can occur under physiological 
conditions. This autolyzed calpain is highly sensitive to even very low concentrations of 







Figure 2.9. Mechanistic representation of Activation of m-Calpain by Ca2+. Ca2+ and 
phospholipids (PL) bind to the acidic loop, resulting in unfolding of the sub-domains of 
dII that brings the two sub-domains closer, leading to the catalytic site formation and 
dissociation of the 28kDa from 78kDa. K7 and D154 form a salt bridge in the absence of 
Ca2+. Cys C105 and His H262 are amino acid residues at the catalytic site; Nt, NH2- 
terminal; - and + are the acidic and basic amino acid residues necessary for calcium 
binding. (Taken from Suzuki et al. [156].) 
  
 
2.5. (R) - N-ACETYLCYSTEINE AMIDE (NACA).  
 One approach to treating oxidative stress related problems is by using 




However, because of the inefficiency of many compounds in crossing the blood retinal 
barrier, very few compounds have been tried in the treatment of eye disorders. NACA is 
a thiol antioxidant that is a derivative of NAC, an FDA approved drug. It has a molecular 
weight similar to its parent compound, NAC. However, due to the negative charge on 
NAC, the penetration of this compound through cellular membranes is limited. NACA’s 
characteristics as a drug were improved over NAC by neutralizing the carboxylic acid of 
NAC, which made the NACA molecule more lipophilic and, therefore, enhanced its 
ability to penetrate cellular membranes (Figure 2.10). The enhanced ability to penetrate 
cells allowed NACA to be administered at a lower dose than NAC, giving the drug a 
greater therapeutic index and lowering the risk of side effects that are traditionally 
associated with higher doses of NAC [163]. NACA is an excellent source of sulfhydryl 
groups that can be converted by the cells into metabolites capable of stimulating GSH 
synthesis [25]. The molecule can also promote intracellular detoxification and act directly 
as a free radical scavenger. NACA acts as a carrier of NAC and its antioxidant and free 





















With oxidative stress being one of the major contributors of cataracts, many 
antioxidants were tried previously to prevent/treat cataracts. With this background, 
NACA as an eye drop formulation has been tried in this study. To evaluate NACA’s 
ability to prevent/treat cataracts, 3 animal models were used with the first model being 
dexamethasone (Dex) animal study. This is an ex vivo study where Dex was used to 
induce cataracts in the lenses enucleated from Sprague-Dawley rats. The protective role 
of NACA was evaluated by measuring the oxidative stress parameters. The second study 
where C57BL/6 mice were used was the acetaminophen (APAP) cataract model. APAP 
was injected to induce cataracts in mice with NACA being injected 2 h prior to APAP 
injection. One percent NACA eye drops were administered every day after APAP 
injection. The study was carried for 2 weeks to evaluate both preventive as well as 
reversal effects of NACA on APAP-induced cataracts. The third study was performed 
using sodium selenite as a cataract inducer. In this study, selenite was injected into male 
Wistar rat pups on postpartum day (PD) 10 to induce cataracts. One percent NACA eye 
drops were administered starting from PD 15 until the end of week 9 to study the 
preventive effects of NACA on selenite-induced cataracts. The final study was also 
performed with sodium selenite as an inducer of cataract. However in this study, NACA 
was injected (PD 9, 11, 13) prior to selenite injection (PD 10) and 1% percent NACA eye 
drops were administered from PD 15 until PD 30.  The results were indicative of both 
prevention and reversal role of NACA on selenite cataracts. In summary, NACA could 
confer a protective effect by providing a substrate for the generation of GSH, thereby, 
maintains antioxidant levels within the lens. These results indicate that NACA is a 




3.  METHODS 
 
3.1. HPLC ANALYSIS 
 The levels of GSH, GSSG, GSH/ GSSG ratio, and MDA were measured using 
HPLC. 
 3.1.1. Determination of GSH. The levels of GSH in each of the lens samples 
were determined using HPLC, according to a method developed within our laboratory 
[165]. Each of the lens samples was first homogenized in a serine borate buffer (pH 7.8) 
and then centrifuged at 5,000 X g for 10 min at 4 oC. Fifty microliters of the diluted 
supernatant were added to 200 μl of HPLC grade water and 750 μl of N-(1-pyrenyl) 
maleimide (NPM) (1 mM in acetonitrile). The resulting solution was incubated at room 
temperature for 5 min and then the reaction was quenched by the addition of 10 μl of 2 N 
HCl. The samples were then filtered through a 0.45-μm filter and injected onto the HPLC 
system. The HPLC system used was the Finnigan Surveyor (Thermo Scientific), which 
was equipped with an Auto Sampler Plus, LC Pump Plus, and FL Plus Detector. The 
HPLC column used was a Reliasil ODS-1 C18 column (5-μm packing material) with 250 
× 4.6 mm i.d. (Orochem Technologies Inc., Naperville, IL, USA). The mobile phase was 
acetonitrile and water (70:30, v/v) was adjusted to a pH of 2.5 by the addition of 1 ml/L 
of acetic acid and 1 ml/L of phosphoric acid. The NPM derivative of GSH (Figure 3.1) 
was eluted from the column isocratically at a flow rate of 1 ml/min. For detection of this 
derivative, the excitation and emission wavelengths were 330 and 376 nm, respectively. 
 3.1.2. Measurement of Total GSH and GSSG. Total GSH content was 




serine borate buffer (pH 7.8) and then centrifuged at 5,000 X g for 10 min at 4 oC. Fifty 
microliters of the diluted supernatant were added to 60 µl of NADPH (2 mg/ml) in 
nanopure water and 20 µl of 1 unit/ml GR was added, to reduce the GSSG. After 5 min 
of incubation at room temperature, the treated samples were diluted with 120 µl H2O, and 
then immediately derivatized with 750 µl of 1.0 mM NPM. The resulting solution was 
incubated at room temperature for 5 min and then the reaction was quenched by the 
addition of 10 μl of 2 N HCl. These samples were analyzed as detailed for the 
determination of GSH using reverse phase HPLC. Data from the original GSH levels and 
the total GSH levels in each sample were subsequently used to calculate the levels of 
GSSG present in each sample. 
 
 






Figure 3.1. NPM derivatization of Thiol Compounds. NPM reacts with free thiols in 
solution to form a fluorescent NPM-thiol adduct which has an excitation of 330 nm and 










 3.1.3. Determination of MDA. MDA is one of the several low-molecular weight 
end products formed via the decomposition of certain primary and secondary lipid 
peroxidation products [166]. It is the most frequently used biomarker of lipid 
peroxidation. The amount of MDA, a by-product of lipid peroxidation, was determined 
for each sample according to the method described by Draper [167]. For sample 
preparation, 350 μl of the lens homogenate were added to 550 μl of 10% trichloro acetic 
acid (TCA) and 100 μl of 500 ppm butylated hydroxytoluene in methanol. The resulting 
solution was then boiled for 30 min in a water bath. After cooling in an ice-water bath, 
the solutions were centrifuged and the supernatant was collected. This supernatant was 
then added 1:1 with a saturated solution of thiobarbituric acid (TBA). Again, the contents 
were heated in a boiling water bath for 30 min and then immediately cooled in an ice 
water bath. The TBA-MDA adduct (Figure 3.2) was then transferred into n-butanol by 
adding 500 μl of the sample mixture into 1 ml of n-butanol and vortexing each sample for 
one min. Each sample was then centrifuged at to facilitate the separation of the two 
phases. The resulting organic layers were first filtered through 0.45-μm filters and then 
injected onto the HPLC system (Finnigan Surveyor, Thermo Scientific), which was 
equipped with an Auto Sampler Plus, LC Pump Plus, and FL Plus Detector. The HPLC 
column used was a Reliasil ODS-1 C18 column (5-μm packing material) with 250 × 4.6 
mm i.d. (Orochem Technologies Inc., Naperville, IL, USA). The mobile phase used 
contained 69.4% sodium phosphate buffer, 30% acetonitrile, and 0.6% tetrahydrofuran. 
The fluorescent derivative was monitored at an excitation wavelength of 515 nm and an 








Figure 3.2. Formation of TBA-MDA adduct. In the presence of TBA, MDA forms a 




3.2. SPECTROPHOTOMETRIC STUDIES 
 The enzyme activities of GR and Ttase along with the protein levels were 
measured using UV/Vis spectrophotometer, whereas calcium levels were measured using 
Atomic absorption spectrophotometer. 
 3.2.1. GR Activity. GR is the enzyme responsible for recycling GSSG into GSH 
via a reduction mechanism, utilizing both GSSG and NADPH as a substrate. The activity 
of this enzyme was determined using a commercial kit from OxisResearch (Portland, OR, 
USA). The oxidation of NADPH to NADP+ was accompanied by a decrease in 
absorbance at 340 nm, providing a spectrophotometric means for monitoring the enzyme 
activity of GR. The activity of GR was determined by adding homogenate to a solution 
containing both GSSG and NADPH and then recording the absorbance as a function of 
time at 340 nm. The rate of decrease in the A340 was directly proportional to the GR 
activity in the sample. 
 3.2.2. Thioltransferase (Ttase) Activity. The Ttase activity was determined by 
the method of Wang [168]. Briefly, the reaction mixture contained 0.1 M phosphate 
buffer (pH 7.5), 0.2 mM NADPH, 0.5 mM GSH, and 0.4 units of GR. The reaction 
mixture (0.8 ml) and an aliquot of a homogenized sample (lens, 0.1 ml) were combined 




and then centrifuged to remove particulates. Hydroxyethyl disulfide (20 mM, 0.1 ml) was 
added to initiate the reaction that was monitored at 340 nm for 2 min. Reaction mixtures 
without the substrate were used as blanks. 
 3.2.3. Determination of Calcium Concentration. The lenses from all groups 
were analyzed to determine the Ca2+ concentration, as described by Elanchezhian [169]. 
Briefly, lenses were placed in acid washed tared glass vials, heated at 100 oC for 20 h, 
and dry weights were recorded. Concentrated HCl (0.2 ml) was added to digest the lenses 
overnight and diluted to 1 ml with deionized water. The samples were then centrifuged at 
10,000 X g for 10 min to remove insoluble materials. The supernatant fractions were 
collected to measure the calcium concentration using an atomic absorption 
spectrophotometer (model Spectra AA-3100, Perkin Elmer), operated with a slit width of 
0.5 nm, and wavelength set at 422.7 nm. Standards were prepared from CaCO3 and 
deionized water. 
 3.2.4. Total Protein Determination. Protein levels of the lens homogenates were 
measured by the Bradford method [170], except for casein zymography and the Western 
blot where the Bio-Rad DC protein assay was used. This was because the lysis buffer 
(mentioned in the “Preparation of water-soluble lens proteins” section) contained 1% 
detergent which would interfere with the results of the Bradford assay.  
 Procedure for the Bradford method is as follows. Concentrated Coomassie blue 
(Bio-Rad, Hercules, CA, USA) was diluted 1:5 (v/v) with distilled water. Twenty 
microliters of diluted lens homogenate were then added to 1 ml of this diluted dye and the 
solution was then vortexed and allowed to stand at room temperature for 15 min. The 




Scientific Instruments, Columbia, MD, USA). Bovine serum albumin (BSA) was used as 
the protein standard. 
 Procedure for the Bio-Rad DC protein assay is as follows. ‘Working reagent A’ 
was prepared by adding 20 µL of reagent S to 1 ml of reagent A. One hundred microliters 
of diluted lens homogenate was then added to 500 µL of working reagent A and vortexed 
for proper mixing. To this, 4 ml of reagent B was added, and the solution was vortexed 
and allowed to stand for 15 min. The absorbance was measured at 750 nm. BSA was used 
as a protein standard. 
 
3.3. GEL ELECTROPHORETIC STUDIES 
 SDS-PAGE and Western blots were performed using polyacrylamide gels, 
whereas, casein zymography was performed using casein zymogram gels. 
 3.3.1. Casein Zymography.  Casein zymography was performed using the 
method of Raser [171]. Casein zymogram gels were purchased from Bio-Rad. Protein 
concentration was determined using the Bio-Rad DC protein assay with BSA as a 
standard. A zymogram sample buffer was added to the supernatant of an equivalent 50 µg 
of protein, so that the final volume was 30 µL. The gels were prerun at 100 V for 15 min, 
4 oC, with a running buffer containing 25 mM Tris-HCl, 0.05% MCE, 192 mM glycine, 
and 1 mM EDTA (pH 8.3), before samples were loaded into the wells. Twenty five 
microliters of each sample were loaded and electrophoresed at 100 V (constant) for 2 h at 
4 oC in a running buffer. The gels were then incubated in a calcium buffer (20 mM Tris–
HCl, 10 mM DTT, 2 mM calcium, pH 7.4) overnight at room temperature with slow 




achromatic bands of caseinolysis appeared white against a stained background. 
 3.3.2. Preparation of Water-Soluble Lens Proteins. Rats were euthanized and 
their eyes were enucleated. Four decapsulated lenses from each group were homogenized 
in 600 µL of lysis buffer [(Cell Signaling Technology, Inc., Danvers, MA, USA) 20 mM 
Tris-HCl (pH 7.5); 150 mM NaCl; 1 mM Na2EDTA; 1 mM EGTA; 1% Triton; 2.5 mM 
sodium pyrophosphate; 1 mM beta glycerophosphate; 1 mM Na3VO4; 1 µg/ml leupeptin; 
2 mM PMSF] using a glass Dounce homogenizer. The homogenates were centrifuged at 
10,000 X g for 15 min at 4 oC and the recovered supernatants were designated as the 
water-soluble fraction. 
 3.3.3. SDS-PAGE of Lens Soluble Proteins. A SDS-PAGE of the soluble lens 
proteins was performed on a 10% Mini-Protean TGX gel (Cat no: 456-1034, Bio-Rad, 
Hercules, CA, USA). A 4x Laemmli sample buffer was added to a supernatant, the 
equivalent of 50 µg of protein, so that the final volume was 30 µL. 25 µl of the sample 
were loaded and electrophoresed at 100 V (constant) for 2 h at 4 oC in a running buffer, 
and then stained with coomassie brilliant blue for 30 min followed by de-staining for 1 h. 
 3.3.4. Western Blot of m-Calpain. Lens homogenates were prepared in a lysis 
buffer, and the protein concentration was estimated using a Bio-Rad DC protein assay kit. 
Briefly, 75 μg of soluble lens proteins were resolved by electrophoresis on 10% Mini-
Protean TGX gels (100 V, 2 h) in a running buffer containing 25 mM Tris-HCl, 192 mM 
glycine, 0.05% 2-mercaptoethanol (MCE), and 0.1% SDS (pH 8.3). The samples were 
transferred to PVDF membranes by an iBlot® Gel Transfer Device (Life Technologies, 
Grand Island, NY, USA), followed by the addition of a blocking reagent (blok-CH 




immunoblotted by using the SNAP i.d. 2.0 Protein Detection System (Millipore) with 
primary antibodies for m-calpain and GAPDH in 1:750 and 1: 1000 dilutions, 
respectively. Subsequently, the membrane was incubated in the respective secondary 
antibody (1:1000) for 10 min at room temperature. Final visualization was carried out 
with the enhanced chemiluminescence kit (Cell Signaling Technology, Inc., Danvers, 
MA, USA). The protein bands were quantitated by densitometry, where the band 
intensity ratio of the treated group over the untreated group, or control, was calculated. 
 
3.4. CATARACT EVALUATION 
 The scale used to grade the intensity of opacification of each lens was defined as 
follows: clear lens, grade 0; lens with slight opacity, grade 1; lens with partial nuclear 
opacity, grade 2; lens with dense nuclear opacity, grade 3. All rat pups/mice received a 
drop of 2.5% phenylephrine hydrochloride and a drop of 1% tropicamide ophthalmic 
solution in each eye to initiate mydriasis, and were placed in a dark room for 1 h before 
the examination. The animals were put to sleep by placing them in an isoflurane/oxygen 
chamber that is well regulated for 2-5 mins (leaving them for more time will ultimately 
lead to death of the animal). The lenses of each rat/mouse were then observed using a 
slit-lamp microscope at 10× magnification. The degree of opacity in each lens was 
determined and verified by a certified ophthalmologist (Dr. Humeyra Karacal, 
Ophthalmologist, Washington University School of Medicine in Saint Louis) and then 





3.5. WATER CONTENT 
 For this experiment, first the weight of each clean vial (V1) was recorded, lenses 
were placed into these vials, and the weight of the lens along with the vial (V2) was 
recorded. The difference between these two gave the weight of the wet lens (V3). The dry 
weight of the lens (V4) was measured after heating at 100 
oC in an oven for 24 h. The 
difference between the wet weight of the lens (V3) and the dry weight of the lens (V4) 
gave the water content of the lenses among different groups. 
 
3.6. STATISTICAL ANALYSIS 
 All reported values were represented as the mean ± S.E of quadruplets. Statistical 
analyses were performed using GraphPad Prism software (GraphPad, San Diego, CA, 
USA). Statistical significance was ascertained by one-way analysis of variance, followed 




4. N-ACETYLCYSTEINE AMIDE PROTECTS AGAINST DEXAMETHASONE-
INDUCED CATARACT RELATED CHANGES IN CULTURED RAT LENSES 
 
 
 Glucocorticoids (GCs) are steroid hormones that play a role in physiological 
processes and are widely used as immunosuppressive and anti-inflammatory agents in the 
treatment of many clinical conditions, including rheumatoid arthritis, asthma, 
autoimmune diseases, and various ocular diseases [172, 173]. However, their clinical use 
is restricted due to a wide range of complications associated with their long-term topical 
and systemic use. One of the ocular complications of glucocorticoid toxicity is the 
development of posterior subcapsular cataracts (PSCs) [174-179]. Unfortunately, certain 
patients cannot avoid long-term steroid therapy and, therefore, development of adjunctive 
therapeutics for the prevention of steroid-induced cataracts is highly desirable. 
 Oxidative stress and depletion of GSH are implicated in the etiopathogenesis of 
glucocorticoid-induced cataracts [10, 11, 180-183]. Epidemiological studies have 
documented loss of GSH in various types of cataracts [184-186]. A decrease in GSH 
levels after glucocorticoid exposure [187, 188], along with an increase in the levels of 
lipid peroxide in the lens [188], have been reported.  Furthermore, protection by 
antioxidants, like Vitamin E and ascorbic acid [178, 189], against damage caused by a 
soluble corticosteroid suggests the role of oxidative stress in steroid-induced cataract 
formation. 
 Promising results with NACA [22-24, 26, 28, 190, 191] in various oxidative 
stress-related disorders encouraged us to investigate the protective role of NACA in the 
prevention of dexamethasone (DEX), a synthetic glucocorticoid, induced cataracts. Our 




peroxidation and increasing the ratio of GSH/GSSH in a lens. NACA can potentially be 
developed into a promising adjunctive therapeutic option for patients undergoing 
therapy with glucocorticoids. 
 
4.1. EXPERIMENTAL DESIGN 
 Lactating female Sprague-Dawley rats, with 30 male 14-day-old pups, were 
purchased from the breeding facility at Charles River and were housed in a temperature- 
(~22 °C) and humidity- (~55%) controlled animal facility, with a 12 h/12 h light/dark 
cycle. The animals had unlimited access to rodent chow and water and were utilized after 
3 days of acclimatization. All animal procedures conformed to the ARVO Statement for 
the Use of Animals in Ophthalmic and Vision Research and guidelines of the Animal 
Care and Use Protocol Review Committee at the Missouri University of Science and 
Technology. For rat lens culture, eyes from 21-day-old rats were enucleated to expel the 
lens using plastic-coated forceps and fine scissors. Eyes were immediately transferred to 
Dulbecco’s MEM (pH 7.2; Sigma, St. Louis, MO), containing 0.1% bovine serum 
albumin (BSA; GibcoBRL, Grand Island, NY) and antibiotic solution (GibcoBRL; 100 
U/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B) [192]. The 
culture media was changed daily. Approximately 24 h after the preparation of organ 
cultures, clear lenses were selected and were randomly divided into four groups with 8 
lenses in each group: (1) control group (Dulbecco’s Modified Eagle Medium (DMEM)), 
(2) Dex group (5 µM Dex dissolved in DMEM), (3) NACA-only group (50 µM NACA in 
DMEM), and (4) NACA pretreatment group (pretreatment with 50µM NACA for 6 h, 




the DMEM media (as detailed above) for 7 days at 37°C under 5% CO2. Old media was 
replaced with fresh media every day and the lenses were evaluated daily, using a 
dissecting microscope and photographed to check for the development of opacity. 
 
4.2. RESULTS 
 The results indicate the effects of NACA and Dex on various oxidative stress 
parameters. The change in these parameters in the NACA-only group were similar to 
those observed in the control group. Hence the levels of NACA were not reported in the 
bar graphs. 
 4.2.1. Prevention of Dex-Induced Cataracts by NACA. To examine the effects 
of Dex on the lens, an ex vivo rat lens model was used. Rat lenses were isolated and were 
treated in an organ culture to directly cause steroid-induced cataracts. The lenses were 
incubated with 5 µM Dex and morphologic changes in the whole lenses were recorded 
photographically using a dissection microscope. Opacity first appeared at day 3 in the 
lenses incubated with Dex. All the 8 lenses in the Dex group developed cataracts by day 
7. In contrast, only 25% of the lenses developed cataracts in the NACA pretreatment 
group. Untreated control lenses remained transparent until day 7 (Figure 4.1). 
 4.2.2. Effects of NACA on Intracellular GSH Levels in Dex-Treated Cultured 
Rat Lens. To support the hypothesis that GSH depletion would induce cataract formation 
in the Dex-treated group, the levels of intracellular GSH were measured. Figure 4.2 
shows the effect of Dex on lens GSH levels in the presence and absence of NACA. A 7-
day exposure to 5μM of Dex decreased the GSH level to 21% of that of the control. A 




4.2.3. Effect of NACA on Oxidized Glutathione (GSSG) Levels and 
GSH/GSSG Ratio in Dex-Treated Cultured Rat Lens. GSSG levels in the lens of the 
Dex-only group were found to have significantly increased by approximately three times 
the GSSG levels in the control group. The amounts of GSSG found in the lenses with 
NACA pretreatment were significantly lower as compared to the Dex-only group and 
were close to that of the control group. A graph showing these results is in Figure 4.3.  An 
interesting result was obtained by observing the ratio between the GSH and the GSSG 
levels in the lenses of each group. As expected, the control group was found to have the 
highest ratio of GSH to GSSG. The ratio dropped to about 6% of control in the Dex-only 
group (Figure 4.4). However, NACA pretreatment increased this ratio significantly to 
approximately 50% of the control group value. 
4.2.4. Effect of NACA on GR Activity in Dex-Treated Cultured Rat Lens. GR 
is a key antioxidant enzyme involved in maintenance of cellular GSH homeostasis. It 
reduces GSSG back to the reduced form, GSH. A significant reduction in the activity of 
GR was observed upon Dex treatment. However, NACA pretreatment increased the 
activity of GR (Figure 4.5). 
 4.2.5. Effect of NACA on LPO Byproduct: MDA. MDA was used as an index 
of LPO. Dex-treated lens had significantly higher levels of MDA, as compared to those 
of the control (Figure 4.6). Pretreatment with 50 µM of NACA completely reduced this 
increase, with MDA levels becoming nearly the same as those of the control, and with a p 
value of <0.05, as compared to that of the control. The NACA-only treated group showed 




4.3. DISCUSSION  
A posterior sub-capsular cataract is one of the ocular complications of glucocorticoid 
(GC) toxicity. Despite a well-established link between the use of GCs and cataracts, 
treatment with GCs cannot be avoided in some cases. GC-induced cataract formation is 
directly attributed to oxidative stress that occurs within the lens. Oxidation, which can be 
caused by an overabundance of oxidative stress generators, such as molecular oxygen,          
hydrogen peroxide, and free radicals, produces a major insult upon the lens, which can 
lead to the loss of GSH, lipid peroxidation, and a decrease in antioxidant enzyme activity 
[193-195]. GSH is an indispensable and primary lenticular antioxidant [183]. A wide 
body of evidence indicates loss of GSH because of its oxidation to GSSG, since its levels 
increase drastically once cataracts develop. Therefore, an alternative method for treating 
or preventing the occurrence of GC-induced cataracts would be through the use of a GSH 
prodrug. With this background, we evaluated the effects of a novel antioxidant and a 
potent GSH prodrug, N-acetylcysteine amide (NACA), in the prevention of cataracts 
induced by Dex in rat lenses. Results from morphological observations indicated that 
NACA was able to reduce the opacification of the lens within this ex vivo Dex-induced 
cataract model (Figure 4.1). 
 As discussed earlier, GSH is an essential lenticular antioxidant and is present in 
high concentrations in the lens, providing a first line of defense against oxidative damage 
[5], as well as playing an important role in antioxidant defense and redox regulation [9].  
Results from this study indicate that treatment with Dex decreased lenticular GSH and 
the GSH/GSSG ratio significantly. In addition, it increased GSSG levels significantly. 




decreasing the levels of GSSG.  The ratio of reduced to oxidized glutathione 
(GSH/GSSG) serves as a representative marker of the antioxidative capacity of a cell. 
Depletion of GSH could be due to several possible mechanisms, including, but not 
limited to the efflux of GSH from the lens, sequestration of GSH by incorporation into 
mixed disulfide aggregates, enhanced consumption of GSH in the process of 
detoxification of ROS, and downregulation of enzymes involved in GSH biosynthesis. 
Another possible explanation for the decrease in GSH levels under oxidative stress is the 
reduced GR activity. Some studies have indicated that loss of GSH will directly affect the 
activity of the GSH-dependent enzyme GR. This enzyme plays an important role in GSH 
homeostasis. It has been reported that, under oxidative stress, the protein sulfhydryl 
(protein–SH) groups are lost [196], which are essential for enzyme activity [197]. Under 
such circumstances, GSH is not regenerated, so depletion of GSH indicates that the tissue 
is undergoing oxidative stress. The decreased activity of GR seen in this study with Dex 
treatment supports the hypothesis of GSH depletion upon treatment with Dex. A decrease 
in the lenticular GSH levels has been observed upon treatment with GCs [10, 187, 198]. 
In vivo treatment of rabbits with the Dex eye drops, as used for cataract surgery, reduced 
GSH levels in the lens [198]. In addition, free radical scavengers have also been reported 
to prevent GC-induced cataract formation [199-201] by increasing GSH levels and 
decreasing lipid peroxides (LPOs). 
 Decreasing the levels of GSH, when ROS are present can trigger a cascade of 
further oxidative damage. LPO has been associated with the formation of cataracts in 
patients [202-204]. The extent of LPO was determined in this study by measuring the 




substrate for GPx stalled the process of LPOs decomposition and, thus, increased the levels 
of MDA in the Dex-treated group. NACA supplied an adequate amount of GSH as a 
substrate for GPx to effectively decompose LPOs in the rats, reducing MDA levels (Figure 
4.6). The multiple roles of NACA in preventing cataract formation include direct 
scavenging of free radicals, providing cysteine for GSH synthesis, and nonenzymatic 
reduction of the preexisting toxic GSSG into GSH. 
 These results suggest that NACA can prevent the formation of Dex-induced 
cataracts by directly and indirectly maintaining the GSH/GSSG ratio in healthy lenses, 
allowing the lens to better cope with oxidative stress. NACA could confer a protective 
effect by providing a substrate for the generation of GSH, maintaining antioxidant levels 
within the lens and, possibly, through disulfide-exchange mechanisms. Treatment with 
NACA may prove to have a major therapeutic role in Dex-induced cataracts. In future 
studies, the focus will be on the prophylactic role of NACA in GC-induced cataract 
formation and investigate the development of a topical formulation for the application of 
this antioxidant in an in vivo model.  
 
 
              
 
Figure 4.1. Appearance of Cultured Rat Lens with Dex and NACA at Day 7. Opacity was 
observed only in the Dex group at day 7 (Figure 1.C), which was significantly prevented 
by pretreatment with NACA. A: Control; B: NACA –only; C: 5 µM Dex; D: 5 µM Dex + 








    
 
Figure 4.2. Intracellular GSH Levels in Lens after Treatment with Dex and NACA. GSH 
levels were measured after 7 days of treatment for control, NACA, Dex, and Dex + 
NACA groups. Exposure to Dex (5 μM) significantly decreased intracellular GSH levels. 
Pretreatment with NACA (50 µM) prevented such a dramatic decrease. The NACA-only 
treated group showed no significant difference when compared to the control. *p ≤ 0.05 








Figure 4.3. Intracellular GSSG Levels in Lens after Treatment with Dex and NACA. The 
GSSG level was significantly higher in the Dex-only group than in the control. This 
GSSG level was significantly reduced upon pretreatment with NACA. The NACA-only 
treated group showed no significant difference when compared to the control. *p ≤ 0.05 







Figure 4.4. GSH/GSSG Ratio in Lens after Treatment with Dex and NACA. The 
GSH/GSSG ratio in the Dex only group was significantly lower than in the control group. 
This GSH/GSSG ratio was significantly increased upon pretreatment with 50uM NACA. 
The NACA-only treated group showed no significant difference when compared to the 








Figure 4.5. GR Activity in Lens after Treatment with Dex and NACA. GR activity was 
significantly lower in the Dex-only group than in the control group, while NACA 
pretreatment increased its activity. The NACA-only treated group showed no significant 
difference when compared to the control. *p ≤ 0.05 compared to the control group, and 






Figure 4.6. MDA Levels in Rat Lens after Treatment with Dex and NACA. It was found 
that, after 7 days of Dex treatment, the MDA levels significantly increased. Dex (5 μM) 
induced a significant increase in the MDA level. Pretreatment with 50 µM of NACA 
decreased lipid peroxidation significantly. *p ≤ 0.05 compared to the control group, and 




5. EFFECTS OF N-ACETYLCYSTEINE AMIDE EYE DROPS ON 




 Acetaminophen (N-acetyl-p-aminophenol; APAP), one of the most widely 
prescribed medications in the world is an analgesic and antipyretic drug which is 
considered to be safe when used at a therapeutic dose [205]. However, at high doses, 
APAP may cause severe damage to the liver [206-218], and has been reported to be the 
most important cause of acute liver failure in many nations [214, 219-221]. In addition to 
liver failure, APAP also has an adverse effect on kidneys [222], the pancreas resulting in 
pancreatitis [223], and the lens causing cataracts [224-229]. APAP gets transformed to a 
reactive and toxic metabolite, N-acetyl-p-benzoquinone imine (NAPQI) in the presence 
of hepatic cytochrome P450 (CYP) enzymes (Figure 5.1) [205, 230-232]. At a 
therapeutic dose of APAP, this NAPQI undergoes conjugation with GSH and gets 
eliminated from the body; however, at a higher dose, NAPQI depletes the GSH stores by 
approximately 90% , subsequently binding to the cysteine residues of other proteins, 
leading to the formation of APAP-protein adducts, and thereby causing toxicity [233-
235]. Qian and Shichi [236] suggested that the “NAPQI formed from the 
biotransformation of APAP by CYP is transported by blood circulation to the eye, 
secreted with the aqueous humor, flows to the anterior chamber, and causes damage to 
the lens epithelium”. Histological studies revealed structural and functional changes of 
mitochondria in mice injected intracamerally with NAPQI [237] and increased 
intracellular free calcium levels, leading to the activation of calpains [226]. 
Mitochondrial dysfunction leads to increased production of ROS that regulates the 















Figure 5.1. APAP Biotransformation to NAPQI 
    
 
 Antioxidants are becoming more widely used in preventing as well as treating 
oxidative stress related disorders. As oxidative stress and GSH depletion were reported as 
important events in the development of cataracts by APAP, use of GSH prodrugs could 
slow down or prevent the cataract progress. Previous in vivo studies using different 
prodrugs such as mercaptoethanol/L-cysteine mixed disulfide (CySSMe) [228], diallyl 
disulfide + N-acetylcysteine [227] have been shown to be successful in preventing 
APAP-induced cataract formation.  
 In this study, the role of NACA in preventing APAP-induced cataracts in 
C57BL/6 mice was evaluated. Cataracts were induced by intraperitoneal injection of β-
naphthoflavone (CYP inducer) into C57BL/6 mice, 3 days prior to APAP injection. To 
evaluate NACA’s ability to prevent cataract formation, NACA was injected 
intraperitoneally 2 h prior to APAP injection and NACA eye drops were continued until 
the conclusion of the experiment. The results suggest that NACA prevented cataract 
formation by increasing the GSH levels, GSH/GSSG ratio, GR and Ttase activities, while 







5.1. EXPERIMENTAL DESIGN 
 Sixteen C57BL/6 mice (male, 4-6 weeks of age, each weighing 20-24 g) were 
purchased from the Jackson Laboratory (Bar Harbor, ME, U.S.A) and were housed in a 
temperature- (~22 °C) and humidity- (~55%) controlled animal facility, with a 12 h/12 h 
light/dark cycle. The animals had unlimited access to rodent chow and water and were 
utilized after 3 days of acclimatization. All animal procedures were conducted under an 
animal protocol approved by the Institutional Animal Care and Use Committee of the 
Missouri University of Science and Technology. The mice were divided into four groups, 
(1) control, (2) APAP-only, (3) NACA-only, and (4) NACA + APAP. Three days prior to 
APAP injection, β-naphthoflavone (37.5 mM) was prepared in warm corn oil and injected 
intraperitoneally (0.02 ml/g body wt.) into the mice belonging to the APAP-only and the 
NACA + APAP groups to induce CYP [228]. Warm corn oil was injected in the control 
and the NACA-only groups. APAP was also prepared in warm corn oil and was injected 
intraperitoneally (0.15 mmol/ml, administered at a level of 0.02 ml/g body wt.) into the 
APAP-only and the NACA + APAP groups. All mice in the NACA-only and the NACA 
+ APAP groups received an intraperitoneal injection of NACA (250 mg/kg body wt., 
prepared in 25 mM phosphate buffer, pH 7.4), 2 h before APAP injection , whereas, 
phosphate buffer was injected in the control and the APAP-only groups. Cataracts were 
observed within the first 5 h of APAP injection in the APAP-only group. One percent 
NACA eye drops (prepared in 25 mM phosphate buffer, pH 7.4) were continued for 2 
weeks before sacrificing the animals. Grading of the cataract formation was performed 
with the help of a slit microscope on the last day of eye drops, along with picture 




or buffer eye drop by intraperitoneal injection with a 40% urethane solution (0.1 ml/10 g 
body wt.). After sacrifice, their lenses were harvested, and then immediately placed on 
dry ice. Samples were stored at a temperature of −80 °C for further analysis. The lenses 
were then analyzed for oxidative stress parameters, such as GSH levels (reduced and 
oxidized), MDA levels, GR and Ttase activities. 
 
5.2. RESULTS 
 The results indicate the effects of NACA and APAP on various oxidative stress 
parameters. 
 5.2.1. Effects of APAP and NACA on Cataract Formation in the Lens. 
Administration of an injection of 0.2 ml/g body wt. of 0.15 mmol/ml of APAP was 
significant enough to cause the development of cataracts. Upon examination with a slit-
lamp microscope, it was also found that all of the mice within the APAP-only group 
developed cataracts and were classified as grade 3. However, in the mice treated with 
NACA in conjunction with APAP, it was found that only 25% of the lenses had shown 
opacity. The majority of lenses were of a clarity similar to that seen in the control group. 
Lenses observed within the control and the NACA-only groups were completely clear. 
The grading of the lens in all of the groups is tabulated in Table 5.1, and the slit-lamp 
pictures of representative lenticular opacities observed for each group are shown in 
Figure 5.2. 
 5.2.2. Effects of NACA on GSH and GSSG Levels in the Lens. GSH levels in 
the lenses of the rat pups in the APAP-only group were found to be significantly (p < 




Table 5.1. Classification of Degree of Cataract Formation in Mice after NACA Treatment  
Group (n=4) Grade 0 Grade 1 Grade 2 Grade 3 
Control 4 0 0 0 
NACA-only 4 0 0 0 
APAP-only 0 0 0 4 




treatment with NACA in the NACA + APAP group (Figure 5.3) significantly (p < 0.05) 
increased the GSH levels compared to that of the APAP-only group.  
 GSSG levels in the lenses of the APAP-only group were found to be significantly 
(p < 0.05) increased by approximately ten times the GSSG levels in the control group. 
However, treatment with NACA in the NACA + APAP group had significantly (p < 
0.05) decreased the GSSG levels similar to those of the control. The GSSG levels in the 
NACA-only group were found to be similar to those of the control group (Figure 5.4).  
 A similar trend was observed with the ratio between the GSH and the GSSG 
levels in the lenses of each group. As expected, the control group was found to have the 
highest ratio of GSH to GSSG. A significant (p < 0.05) reduction (approximately 90%) of 
the ratio GSH to GSSG was observed in the APAP-only group when compared to those 
of the control group. However, an increase in the GSH to GSSG ratio was seen in the 
NACA + APAP group when compared to the APAP-only group, but was not 




 5.2.3. Effects of NACA on GR and Ttase Activities in the Lens. The activities 
of two major antioxidant enzymes: GR, and Ttase were measured within the lens.  
Significant (p < 0.05) reductions in GR, and Ttase activities were observed in the lenses 
of animals injected with APAP in comparison with those of the control group and the 
NACA-only group. However, the mice that were treated with NACA showed increased 
enzyme activities, compared to the APAP-only group (Figure 5.6 and 5.7). No significant 
differences between GR, and Ttase activities for the control and the NACA-only groups 
were determined. 
 5.2.4. Effects of NACA on Lipid Peroxidation in the Lens. The levels of MDA, 
the byproduct of lipid peroxidation, were measured in the lens samples and were 
consistently high in lens containing cataracts. The results suggest a significant (p < 0.05) 
twofold increase in MDA levels in the APAP-only group compared to the control group. 
However, MDA levels in the lenses of the mice belonging to the NACA + APAP group 
showed a significantly larger (p < 0.05) reduction than those in the APAP-only group and 
approached levels similar to those of control (Figure 5.8). 
 
5.3. DISCUSSION 
 The cytotoxicity of APAP depends on the metabolic transformation of APAP to 
NAPQI by cytochrome P450 enzymes (CYP) [205, 230-232, 238]. At normal levels of 
APAP, the CYP enzyme activation of APAP and its conversion to NAPQI is not enough 
to cause a cataract as it is eliminated from the body by conjugating with GSH, whereas at 
higher doses of APAP and a CYP inducer (such as β-naphthoflavone), the NAPQI that is 




secreted with aqueous humor and damages the lens epithelium, resulting in a cataract 
[224-229]. Studies have demonstrated that NAPQI covalently binds to cellular organelles 
[206] such as mitochondria [239], and similar to cyanide, NAPQI disrupts the 
mitochondrial membrane causing the loss of mitochondrial membrane potential and 
depletion of ATP [240]. The loss of mitochondrial membrane integrity results in 
increased ROS generation, leading to oxidative stress which can lead to the loss of GSH, 
lipid peroxidation, decreased antioxidant enzyme activities and dysregulation of signal 
transduction pathways [193-195].  
 With oxidative stress and GSH depletion being involved in the etiology of an 
APAP-induced cataract, an antioxidant that can replenish GSH levels can be tried to treat 
this APAP-induced cataract. Based on this, we evaluated the effects of a novel 
antioxidant and a potent thiol-exchange compound NACA to prevent as well as treat 
cataracts induced by APAP. Morphological examination (Figure 5.1) of the lenses 
indicated that NACA was able to prevent the formation of cataracts in the NACA + 
APAP group in about 75% of the mice, whereas a grade 1 cataract was observed in one 
mouse (Table 5.1). However, all the mice in APAP-only group had grade 3 cataracts.  
 As discussed earlier, GSH being an important antioxidant in the lens, provides the 
first line of defense against oxidative damage caused by ROS [5]. It is present in 
unusually high concentrations in the lens and is responsible for lens transparency [133]. 
Previous studies have indicated that depletion of GSH levels precedes the formation of 
cataracts [130, 132, 133, 136, 137, 182, 241], resulting in oxidation of protein sulfhydryl 
groups and, thereby, causing cataracts [203]. Results from this study indicated a 




that of the control group. On the other hand, NACA being a GSH prodrug, increased the 
GSH levels in the NACA + APAP group (Figure 5.2). This might be due to NACA’s 
ability to donate sulfhydryl groups for GSH synthesis [191] and also through reduction of 
GSSG to GSH, by nonenzymatic thiol disulfide exchange [24].  These results are in 
agreement with previous results that have reported a decrease in GSH levels in the lenses 
upon APAP induction of cataracts in mice [227, 228].  
 GSSG is an oxidized form of GSH which accumulates with increased oxidative 
stress in the cells. Results indicated significantly high levels of GSSG in the lenses of the 
APAP-only group (Figure 5.3) compared to that of the control group lenses, resulting in a 
decreased GSH/GSSG ratio (Figure 5.4). However, treatment with NACA in the NACA 
+ APAP group decreased the GSSG levels significantly and, thereby, increased the 
GSH/GSSG ratio in comparison with the APAP-only group. This could be due to 
decreased GR activity in the APAP-only group (Figure 5.5). The GR catalyzes the 
NADPH dependent reduction of GSSG to GSH, thereby maintaining the intracellular 
GSH pool and reduced environment inside the cell, which is essential for the proper 
functioning of proteins [242]. With decreased GR activity in the APAP-only group, when 
compared to the control group, the conversion of GSSG to GSH could have been 
hindered leading to the accumulation of high GSSG levels in the APAP-only group. On 
the other hand, NACA treatment increased the GR activity in the lenses of the NACA + 
APAP group resulting in decreased GSSG levels. 
 Decreased GSH would lead to accumulation of free radicals in the lenses resulting 
in lipid peroxidation. Lipid peroxidation has been associated with cataract formation 




presence of free radicals and form stable by-products, such as MDA, which are used as 
markers of lipid peroxidation. Lenses from the APAP-only group had significantly higher 
levels of MDA (Figure 5.7), compared to those of the control group lenses, indicating 
increased lipid peroxidation in the APAP-only group. However in the NACA + APAP 
group, treatment with NACA resulted in significant  reduction of lipid peroxidation 
induced by APAP, in comparison to that of the APAP-only group, by providing adequate 
amounts of GSH, a substrate for GPx, an enzyme that catalyzes the conversion of 
hydrogen peroxide to water.  
The Ttase is an enzyme which catalyzes the conversion of protein mixed disulfide 
(PSSG) back to protein thiol (PSH), by using GSH as one of the substrates. During 
cataract formation, oxidative stress builds up, due to diminished levels of GSH, and leads 
to protein-thiol mixed disulfide formation such as crystallin-thiol mixed disulfides, which 
then precipitate within the lens causing a cataract. [244]. This may be due to decreased 
Ttase activity as a consequence of lowered GSH levels during cataract development. 
Depletion of Ttase activity in cataract formation has been previously reported [168, 245, 
246]. Mice injected with APAP had a significantly lowered Ttase enzyme activity, as 
compared to control and, thus, leading to the precipitation of crystallin proteins, whereas 
treatment with NACA in the NACA + APAP group reversed the Ttase enzyme activity 
(Figure 5.6). This reversal of Ttase activity by NACA in the NACA + APAP is neither 
significantly different from that of the control group nor the APAP-only group. 
 These results suggest that NACA can prevent the formation of APAP- induced 
cataracts in C57BL/6 mice. This can be attributed to its antioxidant properties that result 




and GR enzyme activities. NACA could confer a protective effect by providing a 
substrate for the generation of GSH, maintaining antioxidant levels within the lens and, 
possibly, through disulfide-exchange mechanisms. Treatment with NACA may prove to 
have a major therapeutic role in Dex-induced cataracts. In future studies, the focus will be 
on evaluating NACA’s ability to reverse the grade of cataracts using in vivo studies. 
 
 
                 
 
                 
 
Figure 5.2. Slit Lamp Images of Eyes. These pictures were taken a day before sacrifice. A 
representative picture of the lenses observed for each group is shown. (A) Lenses from 
control group were found to be clear with no detectable cataracts. (B) Lenses from 
NACA-only group exhibited similar results as that of control, with no detectable 
cataracts. (C) Lenses from APAP-only group exhibited dense nuclear cataracts (100%). 
(D) 75% of lenses from NACA + APAP group exhibited no cataract (grade 0), whereas, 
25% of lenses have developed grade 1 cataracts. 
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Figure 5.3. GSH Levels in the Lens. A: Chromatograms of GSH- dark blue 
chromatogram indicates APAP only, light blue chromatogram indicates NACA + APAP. 
B: Bar graph representation of the GSH level in the NACA-only group was similar to that 
of the control; exposure to APAP significantly decreased the amount of GSH within the 
lens. A significant increase in GSH levels was observed with NACA treatment in NACA 
+ APAP group. ‘*’ refers to significant difference from the control and ‘#’ refers to the 
significant difference from the APAP-only group. 
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Figure 5.4. GSSG Levels in the Lens. The GSSG level in the NACA-only group was 
similar to that of the control; exposure to APAP significantly increased the amount of 
GSSG within the lens. A significant decrease in GSSG levels was observed with NACA 
treatment of the NACA + APAP group. ‘*’ refers to significant difference from the 








Figure 5.5. GSH/GSSG Ratios in the Lens. An accurate measure of the redox status 
within the lens can be obtained with the ratio between GSH to GSSG. The higher the 
value of this ratio, the more of a reduced environment was present within the lens. The 
APAP-only group had a significantly lower ratio than the control group. NACA treatment 
was found to increase this ratio but not to the amount determined within the control 
group. ‘*’ refers to significant difference from the control group, ‘#’ refers to significant 
difference from the APAP-only group, and ‘**’ indicates significant difference from the 









Figure 5.6. GR Activity in the Lens. GR is essential for maintaining the levels of GSH in 
the cell. The results of GR activity in the lens indicated a significantly lower GR activity 
in the lenses of the APAP-only group than in the control group, while NACA treatment in 
the NACA + APAP group increased its activity but not to that of the control. The NACA-
only treated group showed no significant difference when compared to the control. * 




      
                           
 
 
Figure 5.7. Thioltransferase Activity in the Lens. Ttase activity was found to be 
significantly lower in the APAP-only group than in the control group, while NACA 
treatment in the NACA + APAP group increased its activity but not to that of the control. 
The NACA-only treated group showed no significant difference when compared to the 







Figure 5.8. MDA Levels in the Lens. These Results indicate that the amount of MDA in 
the lenses of the NACA-only group were very similar to those of the control group, while 
the APAP-only group showed elevated levels of MDA.  Treatment with NACA in the 
NACA + APAP group was able to retain MDA levels similar to that of the control. ‘*’ 
refers to significant difference compared to the control group and ‘#’ refers to significant 





6. EFFECTS OF N-ACETYLCYSTEINE AMIDE EYE DROPS ON PREVENTION  





A cataract is a cloudiness of the lens region in the eye which attributes to more 
than 50% of the blindness in the world. The selenite-induced cataract model is the most 
commonly used model to study cataracts, as it partially mimics the senile nuclear 
cataracts in humans where oxidative stress plays a major role [247]. Furthermore, Shearer 
proposed the involvement of oxidative stress in selenite-induced cataracts and the 
sequence of events leading to cataract formation [247]. It was hypothesized that the 
oxidative damage caused by selenite possibly involves oxidation of critical sulfhydryl 
groups on calcium ATPase or ion channels, leading to altered metabolism in lens 
epithelium and also in the loss of calcium ATPase activity and, hence, resulting in an 
accumulation of calcium in the nucleus, which could cause activation of m-calpain. 
Activation of m-calpain initiates the proteolysis of β-crystallins leading to the in-
solubilization of proteolyzed β- and α-crystallins; co-precipitating γ-crystallins; and 
ultimately leading to the formation of cataracts.  
Since oxidative stress is implicated in cataract formation, a logical approach to 
counteract cataractogenesis would be the use of an effective lens permeating antioxidant 
that would neutralize and alleviate cumulative oxidative damage. Several compounds 
with antioxidant properties have been reported to prevent selenite-induced cataracts such 
as resveratrol [248], saffron [249], ellagic acid [250], garlic [251], melatonin [252], and 
drevogenin D [253], caffeine [254], ebselen [255] in in vivo, lycopene [256], and N-




and ex vivo [259] as well. In fact, N-acetylcysteine (NAC, a GSH prodrug) has previously 
been tried in selenite-induced cataracts in in vivo [260] and was shown to prevent 
oxidative damage to the lens, slowing down the cataractogenesis.  
Therefore, in this study, the effect of NACA eye drops in preventing as well as 
reversing the selenite-induced cataract in Wistar rat pups was evaluated.  This chapter 
involves two parts and in both parts a single intraperitoneal injection of sodium selenite 
(Na2SeO3, 19-30 µmol/kg body wt.) was given on post-partum day 10 to induce cataracts 
in Wistar rats. In part one, 1% NACA eye drops were administered once a day starting 
from the day rat pups opened their eyes (PD 15) and continued until the end of week 9. 
Morphological examination of the rat eyes was performed at both week 5 and week 9. 
Oxidative stress parameters were evaluated to check the effect of NACA eye drops in 
reversing the cataracts induced by sodium selenite. In part two, intraperitoneal injection 
of NACA (250 mg/kg body wt.) was administered on day 9, 11, and 13 to assess the 
preventive effect of NACA, and 1% NACA eye drops were given once a day, starting PD 
15 (the day rat pups opened their eyes) until PD 30 to check NACA’s ability to reverse 
cataract intensity. Morphological examination of the rat eyes was performed on PD 30. 
Oxidative stress parameters, such as GSH, GSSG, GSH/GSSG, MDA, and calcium levels 
in rat lenses, were determined. GR and Ttase enzyme activities were also quantified. 
Casein zymography and Western blots were performed to study the activity and levels of 
m-calpain. The results suggest NACA’s ability to protect against the cataracts induced by 
sodium selenite. Hence, NACA can potentially be developed into a promising therapeutic 





6.1. EFFECTS OF N-ACETYLCYSTEINE AMIDE ON REVERING SELENITE-
INDUCED CATARACTS IN WISTAR RATS 
  
 This study demonstrates the oxidative stress induced by an injection of sodium 
selenite and the protective effects of NACA eye drops against the oxidative stress. 
6.1.1. Experimental Design. Lactating female Wistar rats with 2-day-old 40 male 
pups were purchased from the breeding facility at Charles River and were housed in a 
temperature- (~22 °C) and humidity- (~55%) controlled animal facility, with a 12-h light 
and dark cycle. The animals had unlimited access to rodent chow and water and were 
used for experiments after a week of acclimation. All animal procedures conformed to the 
ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and by the 
Animal Care and Use Protocol Review Committee at the Missouri University of Science 
and Technology. The rats were divided into four groups: (1) control, (2) NACA-only, (3) 
Na2SeO3-only, and (4) Na2SeO3 + NACA, such that each group had 16 male pups. The 
pups in the Na2SeO3-only group and the NACA + Na2SeO3 were injected 
intraperitoneally with a single dose of sodium selenite (19 µmol/kg body wt.) on post-
partum day 10, whereas 25 mM of phosphate buffer (pH 7.4) was injected into the pups 
from the control group and NACA-only group. Upon the opening of the rat pups eyes, 
cataracts were evaluated using a slit-lamp microscope for each of the animals. Twenty 
microliters of 1% NACA eye drop solution (prepared in sterilized 25 mM phosphate 
buffer pH 7.4) were administered once a day in each eye of the rat pups, starting from PD 
15 until the end of week 9. Lenses of each rat were examined every week to grade the 
intensity of cataracts. Half of the rats from each group were sacrificed at week 5 and the 
lens removed, rinsed with sodium borate buffer, and immediately transferred into liquid 




were then analyzed to determine if NACA showed any improvement in oxidative stress 
parameters, including GSH (reduced and oxidized), GR, and MDA. The remaining half 
of the animals were sacrificed at the end of week 9, and then processed and analyzed as 
described for week 5 lenses (Table 6.1). 
6.1.2. Results. The results indicate the effects of Na2SeO3 and NACA eye drops 
on various oxidative stress parameters. 
  6.1.2.1. Effects of NACA on cataract formation in the lens. A single 
injection of 19 µmol/kg body wt. of Na2SeO3 on PD 10 was significant enough to cause 
the development of cataracts by the time the rat pups opened their eyes. Upon 
examination with a slit-lamp microscope at week 5, it was found that all rats within the 
Na2SeO3-only group developed cataracts, with one out of sixteen (6.25%) developing 
grade 1 cataracts, three rats (18.75%) had grade 2 cataracts, and the remaining twelve of 
the sixteen (75%) developing grade 3 cataracts. However, treatment with NACA eye 
drops in the Na2SeO3 + NACA group did not show any reduction in cataract intensity; 
one rat out of sixteen (6.25%) had grade 1 cataract, four rats (25%) had grade 2 cataracts 
and eleven rats (68.75%) had grade 3 cataracts. All of the rat lenses in the control and the 
NACA-only groups had no signs of cataracts. Hence, NACA eye drops were continued 
for a longer time period to study the reversal effect of NACA on the intensity of cataract 
grade. Continuation of NACA eye drops in the Na2SeO3 + NACA group until the end of 
week 9 resulted in a clear reduction in cataract intensity; three rats out of eight (37.5%) 
had grade 1 cataracts, five rats (62.5%) had grade 2 cataracts, and none of the rats had 
grade 3 cataracts.  Whereas in the Na2SeO3-only group, five rats (62.5%) out of eight 




This morphological examination indicated that prolonged administration (9 weeks) of 
NACA eye drops can reverse the intensity of cataract grade. The grading of the lens in all 
of the groups is tabulated in Table 6.2, and the slit-lamp pictures of representative 
lenticular opacities observed for each group are shown in Figure 6.1  
  6.1.2.2. Effects of NACA on GSH, GSSG and GSH/GSSG ratio in the 
lens. The Lens GSH level is a good indication of redox status in a rat’s eye. At week 5, 
the GSH levels in the lenses of the rat pups in the Na2SeO3-only group were found to be 
significantly (p < 0.05) lower than those in the lenses in the control and the NACA-only 
groups. However, treatment with NACA in the Na2SeO3 + NACA group did not increase 
the levels of GSH significantly when compared to that of the Na2SeO3-only group 
(Figure 6.2.A). The GSH levels in the lenses of the control and the NACA-only group 
showed no significant difference. 
 Interestingly, at the end of week 9, the GSH levels in the lenses of the Na2SeO3-
only group reached back to the levels observed in the control group. While NACA 
treatment in the lenses of the Na2SeO3 + NACA group increased the GSH levels 
compared to those of the remaining groups (Figure 6.2.B).  
 At week 5, the lenses of the Na2SeO3-only group showed increased GSSG levels 
when compared to the lenses of the control group, but not significantly higher, whereas, 
treatment with NACA in the Na2SeO3 + NACA group decreased the GSSG levels 
significantly (p < 0.05), when compared to the Na2SeO3-only group lenses (Figure 
6.3.A). At the end of week 9, the GSSG levels in the lenses of the Na2SeO3-only group 
were neither significantly higher than those of the control group lenses nor those with 




levels compared to those of the Na2SeO3-only group (Figure 6.3.B).  
 At week 5, the GSH/GSSG ratio in the lenses of the Na2SeO3-only group was 
found to be not significantly different from that of the lenses of the control group. 
Whereas, NACA treatment in the Na2SeO3 + NACA group showed a significantly 
increased GSH/GSSG ratio compared to that of the lenses of the Na2SeO3-only group 
(Figure 6.4.A).  The same trend was observed even at the end of week 9; however, 
NACA treatment in the Na2SeO3 + NACA group showed a significantly increased 
GSH/GSSG ratio compared to that of the lenses of the Na2SeO3-only group and also the 
control group lenses (Figure 6.4.B). 
  6.1.2.3. Effects of NACA on MDA levels in the lens. Lipid peroxidation 
was measured based on the levels of MDA, the byproduct of lipid peroxidation. Results 
of week 5 indicated that the amount of MDA in the lenses of the Na2SeO3-only group 
was significantly (p < 0.05) elevated when compared to the lenses of the control group. 
Whereas NACA treatment in the Na2SeO3 + NACA group showed  decreased MDA 
levels, which were close to the levels observed in the control group lenses (Figure 6.5.A).  
 At the end of week 9, the amount of MDA in the lenses of the Na2SeO3-only 
group was found to be significantly (p < 0.05) higher (two and a half times more) than 
that in the lenses of the control group. However, NACA treatment in the Na2SeO3 + 
NACA group lenses showed significantly (p < 0.05) reduced levels of MDA when 
compared to the lenses of the Na2SeO3-only group (Figure 6.5.B) with values that were 
nearly the same as those of the control. 
  6.1.2.4. Effects of NACA on GR activity in the lens. GR is an enzyme 




at week 5 indicated that the activity of this antioxidant enzyme in the lenses of the 
Na2SeO3-only group was significantly (p < 0.05) higher than that in the control group 
lenses. However, NACA treatment in the Na2SeO3 + NACA group showed a significantly 
(p < 0.05) decreased activity of GR than that of the Na2SeO3-only group, with the activity 
approaching close to the activity observed in the control group lenses (Figure 6.6.A). 
Interestingly, at week 9, the GR activity in the lenses of the Na2SeO3-only group was 
close to the activity observed in the control group lenses. Whereas, NACA treatment in 
the Na2SeO3 + NACA group showed a significantly (p < 0.05) increased activity of GR, 
when compared to that of the lenses in the Na2SeO3-only group (Figure 6.6.B). 
 
 
Table 6.1. Classification of Treatment Groups studied 
Groups Animals Injection at PD 10 Eye Drop at PD 14 
Control 16 Phosphate buffer 
(pH 7.4) injection 
Phosphate buffer 
(pH 7.4) 
NACA-only 16 Phosphate buffer 
(pH 7.4) injection 
1% NACA 
Na2SeO3-only 16 Sodium selenite   (19 




Na2SeO3 + NACA 16 Sodium selenite   (19 
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Figure 6.1. Slit Lamp Images of Rat Eyes at Week 5 and Week 9.  A: Control group, B: 
NACA-only group, C: Na2SeO3-only group, D: Na2SeO3 + NACA. In comparison to the 
Na2SeO3-only group, the eyes of rat pups in the Na2SeO3 + NACA did not show any 
reduction in cataract grade at week 5. Continuation of NACA eye drops until week 9, 








Table 6.2. Classification of Degree of Cataract Formation in Rat Pups after NACA 
Treatment. The summary of the degree of cataracts developed by lenses in each group. 
The degrees of opacity are defined as follows: grade 0, normal transparent lens; grade 1, 
initial signs of cataract; grade 2, partial nuclear cataract; grade 3, dense nuclear cataract. 
‘n’ represents the number of animals utilized in each group. 
Week 5 
Group (n=16) Grade 0 Grade 1 Grade 2 Grade 3 
Control 16 0 0 0 
NACA-only 16 0 0 0 
Na2SeO3-only 0 1 3 12 
Na2SeO3 + 
NACA 
0 1 4 11 
 
Week 9 
Group (n=8) Grade 0 Grade 1 Grade 2 Grade 3 
Control 8 0 0 0 
NACA-only 8 0 0 0 
Na2SeO3-only 0 0 3 5 
Na2SeO3 + 
NACA 









Figure 6.2. GSH Levels in the Lens. Comparison of GSH levels of A: week 5, and B: 
week 9. At week 5, the GSH levels in the lenses of Na2SeO3-only group were 
significantly lower than the control group lenses. At week 9, GSH levels in the Na2SeO3-
only group reached a level similar to that in the control group lenses. At week 5, NACA 
treatment in the Na2SeO3 + NACA group did not show any improvement in GSH levels; 
however, NACA treatment in the Na2SeO3 + NACA group lenses, until week 9, showed 
an increase in the GSH levels compared to those in the remaining groups. ‘*’ refers to 








Figure 6.3. GSSG Levels in the Lens. Comparison of GSSG levels of A: week 5, and B: 
week 9. At week 5, the GSSG levels in the Na2SeO3-only group were higher than those of 
the control group lenses. Whereas, NACA treatment in the lenses of Na2SeO3 + NACA 
group significantly reduced the levels of GSSG when compared to the Na2SeO3-only 
group. At week 9, reductions of GSSG levels were observed in the lenses of the Na2SeO3 
+ NACA group when compared to the Na2SeO3-only group. ‘#’ refers to significant 








Figure 6.4. GSH/GSSG Ratio in the Lens. Comparison of GSH/GSSG ratios of A: week 
5, and B: week 9. At week 5, there was a reduction of the GSH/GSSG ratio in the lenses 
of the Na2SeO3-only group compared to the control group; treatment with NACA 
increased this ratio significantly in comparison to the Na2SeO3-only group. A similar 
trend was observed also at week 9. ‘*’ refers to significant difference from the control 
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Figure 6.5. MDA Levels in the Lens. Comparison of MDA levels of A: week 5, and B: 
week 9. At week 5, MDA levels in the lenses of Na2SeO3-only group were significantly 
higher than those of the control group. NACA restored the MDA levels close to the 
control. The same trend was observed also at week 9, with NACA having significantly 
reduced the MDA levels when compared to the Na2SeO3-only group. ‘*’ refers to 
significant difference from the control group, ‘#’ refers to significant difference from the 









Figure 6.6. GR Activity in the Lens. Comparison of GR activity of A: week 5, and B: 
week 9. At week 5, GR activity in the Na2SeO3-only group lenses was significantly 
higher than that in the control group lenses. In contrast, NACA treatment significantly 
reduced the GR activity in comparison to the the Na2SeO3-only group. At week 9, the GR 
activity in the lenses of the Na2SeO3-only group was close to the control group; however, 
NACA treatment significantly increased the GR activity compared to those of the control 
and the Na2SeO3-only groups. ‘*’ refers to significant difference from the control group, 




6.2. EFFECTS OF N-ACETYLCYSTEINE AMIDE ON PREVENTION AND 
REVERSAL OF SELENITE-INDUCED CATARACTS IN WISTAR RATS 
  
 
This study was performed to investigate the preventive as well as the reversal 
effects of NACA on the cataracts induced by a single injection of sodium selenite. 
6.2.1. Experimental Design. Lactating female Wistar rats, with 40 male 2-day-
old pups, were purchased from the breeding facility at Charles River and were housed in 
a temperature- (~22 °C) and humidity- (~55%) controlled animal facility, with a 12-h 
light and dark cycle. The animals had unlimited access to rodent chow and water and 
were used for experiments after a week of acclimation. All animal procedures conformed 
to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and 
by the Animal Care and Use Protocol Review Committee at the Missouri University of 
Science and Technology. The rats were divided into four groups: (1) control, (2) NACA-
only, (3) Na2SeO3-only, and (4) NACA + Na2SeO3, such that each group had one 
lactating female rat with 10 male pups. All rat pups in the NACA and NACA + Na2SeO3 
groups received an intraperitoneal injection of NACA (250 mg/kg body wt.) once a day 
on PD 9, 11, and 13 to check the preventive effect of NACA on selenite-induced 
cataracts, whereas the control and Na2SeO3 groups received an intraperitoneal injection of 
phosphate buffer (pH 7.4) . On PD 10, all rat pups in the Na2SeO3-only and the NACA + 
Na2SeO3 groups received an intraperitoneal injection of sodium selenite (19 µmol/kg 
body wt.), whereas the control and the NACA-only groups received equal volumes of 
phosphate buffer (pH 7.4). One percent NACA eye drops, prepared in phosphate buffer 
(pH 7.4), were started from PD 15 (the day that the rat pups opened their eyes) through 




Na2SeO3 group (Table 6.3). Grading of the cataract formation was performed with the 
use of a slit lamp microscope on PD 15, before starting the eye drops, and on the last day 
(PD 30) before sacrificing the pups. All rats were anesthetized 2-3 h after administration 
of the last NACA or buffer eye drops, by intraperitoneal injection of ketamine (80 mg/kg) 
and xylazine (15 mg/kg). All rat pups were massed at the beginning and the end of the 
study. After sacrifice, their lenses were harvested, and then immediately placed on dry 
ice. Samples were stored at a temperature of −80 °C for further analysis. 
 
 
Table 6.3. Classification of Treatment Groups studied 




Eye Drop from  
PD10 
Control Buffer Buffer Buffer (pH 7.4) 
NACA-only NACA  Buffer 1% NACA 
Na2SeO3-
only 
Buffer Na2SeO3  Buffer (pH 7.4) 
NACA + 
Na2SeO3 
NACA  Na2SeO3  1% NACA 
 
 
6.2.2. Results. The results indicate the effects of NACA and Na2SeO3 on various 






6.2.2.1. Effects of NACA on cataract intensity in the lens. An injection 
of 19 μmol/kg body wt. of Na2SeO3 administered on postpartum day 10 was significant 
enough to cause the development of cataracts by the time the rat pups opened their eyes. 
Upon examination with a slit-lamp microscope, it was found that all rat pups within the 
Na2SeO3 group developed cataracts, with two out of ten (20%) developing grade 3 
cataracts and the remaining eight out of ten (80%) developing grade 4 cataracts. In 
comparison, treatment with NACA intraperitoneal injections decreased the severity of 
cataract formation: eight rats out of ten (80%) developed grade 3 cataracts, while one rat 
formed a grade 1 cataract, and one rat did not develop any cataract (grade 0). These 
results indicated that NACA was successful in preventing cataract formation. By the end 
of week 4, there was no change in the grades of the cataracts in the Na2SeO3-injected rat 
pups [eight out of ten (80%) rats had grade 4 cataracts and two rats had grade 3 
cataracts]. However, treatment with NACA eye drops decreased the severity of cataract 
formation, with five rats out of the ten (50%) having grade 3 cataracts, two rats had grade 
2 cataracts, two rats had grade 1 cataracts, and one rat had no cataract (grade 0). The 
grading of the lens in all of the groups is tabulated in Table 6.4, and the slit-lamp pictures 
of representative lenticular opacities observed for each group are shown in Figure 6.7. 
6.2.2.2. Effects of NACA on GSH and GSSG levels in the lens. GSH 
levels in the lenses of the rat pups in the Na2SeO3-only group were found to be 
significantly (p < 0.05) lower than those of the lenses in the control and the NACA-only 
groups. However, treatment with NACA in the NACA + Na2SeO3 group (Figure 6.8.A) 





GSSG levels in the lenses of the rat pups in the Na2SeO3-only group were found 
to be significantly (p < 0.05) higher than those of the lenses in the control group. 
However, NACA treatment (NACA + Na2SeO3 group) was not able to reduce GSSG 
levels back to the control level (Figure 6.8.B).  
The ratio of GSH and GSSG in the lenses of rat pups in the Na2SeO3-only group 
were found to be significantly (p < 0.05) lower than that of the lenses in the control 
group, whereas, the GSH/GSSG ratio in the NACA treatment group (NACA + Na2SeO3) 
was not significantly different from that of the Na2SeO3-only group or the control group 




                        
Table 6.4. Classification of Degree of Cataract Formation in Rat Pups after NACA 
administration at Weeks 2 and 4. Dense cataract formation was prevented with 
NACA injection in NACA + Na2SeO3 at the end of week 2 when the rats opened 
their eyes. Continuation of NACA eye drops until the end of week 4 decreased the 
number of rats in grade 2 cataract, reversing them to grade 1 cataract. 
 
Groups (n=10) Grade of Cataracts 
(week 2) 
Grade of Cataracts 
(week 4) 
0 1 2 3  0 1 2 3  
Control 10 0 0 0  10 0 0 0  
NACA-only 10 0 0 0  10 0 0 0  
Na2SeO3-only 0 0 2 8  0 0 2 8  




 6.2.2.3. Effects of NACA on MDA levels. MDA levels in the lenses of 
the rat pups in the Na2SeO3-only group were found to be significantly (p < 0.05) higher 
than that of the control group lenses. However, NACA treatment in the lenses of the 
NACA + Na2SeO3 group showed a significant decrease (p < 0.05), with MDA levels 
becoming nearly the same as those of the control (Figure 6.9). 
6.2.2.4. Effect of NACA on GR and Ttase activities. The GR activity in 
the lenses of the Na2SeO3-only group was found to be significantly (p < 0.05) higher than 
those of the control, the NACA-only, and the NACA + Na2SeO3 groups. 
The Ttase activity in the lenses of the Na2SeO3-only group was found to be 
significantly (p < 0.05) lower than that of the control group lenses. However, Ttase 
activity in the NACA treatment group (NACA + Na2SeO3) was not significantly different 
from that of the Na2SeO3-only group or the control group lenses (Table 6.5).     
6.2.2.5. Effects of NACA on water content in the lens. The water 
content in the lenses of the Na2SeO3-only group was found to be significantly (p < 0.05) 
lower than that of the control and the NACA-only groups. However, NACA treatment 
significantly increased the water content in the lenses of the NACA + Na2SeO3 group (p 
< 0.05) compared to that of the Na2SeO3-only group (Figure 6.10). 
6.2.2.6. Effects of NACA on calcium levels in the lens. Lenses in rat 
pups that received Na2SeO3 alone showed significantly (p < 0.05) higher levels of 
calcium than the lenses in the control and the NACA-only groups. However, treatment 
with NACA showed a significant (p < 0.05) reduction in the levels of calcium compared 
to that of the Na2SeO3-only group, with the levels becoming nearly the same as those of 






6.2.2.7. Effects of NACA on casein zymography. The change in the lens 
m-calpain activity among the groups was measured by casein zymography. With the 
evidence of a rise in calcium levels, activation of the calcium dependent protease (m-
calpain) was investigated by observing calcium-activated calpain-mediated lysis of casein 
on the gel. The casein zymogram showed a less intense band of m-calpain in the lenses of 
the Na2SeO3-only group. The intensity of the band in the NACA treatment (NACA + 
Na2SeO3) group was close to that of the control group (Figure 6.12.A).  
6.2.2.8. Effects of NACA on the Western blot of m-Calpain. To support 
our results of casein zymography, Western blot analysis of m-calpain protein was 
performed in the soluble protein fractions of lenses. A less intense band of m-calpain 
protein was observed in the lenses of the Na2SeO3-only group compared to the control 
 




NACA +  
Na2SeO3 
0.77 ± 0.16 
0.92 ± 0.06 
1.3 ± 0.23* 
  0.88 ± 0.16# 
2.0 ± 0.28 
1.8 ± 0.20 
 1.2 ± 0.19* 






Table 6.5. Activities of Antioxidant Enzymes in Rat Pups.  NACA treatment in the NACA 
+ Na2SeO3 group significantly decreased the GR activity when compared to the GR 
activity of Na2SeO3 group lenses. Although NACA increased the thioltransferase activity 
in NACA + Na2SeO3 group, it was not significantly high when compared to that of the 
Na2SeO3 group. Statistical analysis was performed by one-way analysis of variance, 
followed by Tukey’s multiple comparison tests. *p < 0.05 compared to the control group 






group lenses. However, the lenses in the NACA treatment (NACA + Na2SeO3) group 
showed a more intense band when compared with the Na2SeO3-only group (Figure 
6.12.B and 6.12.C). 
6.2.2.9. Effects of NACA on SDS-PAGE of lens soluble proteins. SDS-
PAGE of soluble lens proteins from the Na2SeO3-only group showed the disappearance 
of a number of bands in the molecular weight region of crystallin proteins (19-31 kDa), 
whereas in the lenses of the NACA treatment (NACA + Na2SeO3) group, crystallin 
protein bands were preserved (Fig. 6.13). This indicated that Na2SeO3 caused the 




    
 
     
 
Figure 6.7. Slit Lamp Images of Eyes. These pictures were taken at week 4 (1 day before 
sacrifice). A representative picture of the lenses observed for each group is shown. A: 
Lenses from the control group were found to be clear with no detectable cataracts; B: 
Lenses from the NACA group exhibited similar results to that of the control, with no 
detectable cataracts; C: Lenses from Na2SeO3 group exhibited dense nuclear cataracts 
(80%); D: Lenses from NACA + Na2SeO3 group exhibited a lower grade of cataracts. 







        
          
       
                              
                                      
                                   
Figure 6.8. Effect of NACA on (A) GSH, (B) GSSG, and (C) GSH/GSSG in Lenses of 
Rat Pups injected with Na2SeO3. A: Treatment with NACA significantly increased the 
GSH levels when compared with the Na2SeO3 group. B: Treatment with NACA didn’t 
show a significant decrease in GSSG levels. C: Treatment with NACA increased the 
GSH/GSSG ratio, but it was neither significantly different from the control nor the 
Na2SeO3 group lenses. Statistical analysis was performed by one-way analysis of 
variance, followed by Tukey’s multiple comparison tests. *p < 0.05 compared to the 
control group and #p < 0.05 compared to the Na2SeO3 group. Values are reported as 









Figure 6.9. Effect of NACA on MDA Levels in Rat Pups injected with Na2SeO3. Lenses 
from sodium selenite injected rat pups showed significantly higher levels of MDA 
compared to the control, whereas treatment with NACA significantly decreased the MDA 
levels. Statistical analysis was performed by one-way analysis of variance, followed by 
Tukey’s multiple comparison tests. *p < 0.05 compared to the control group and #p < 







Figure 6.10. Effect of NACA on the Water Content in Rat Pups injected with Na2SeO3. 
Lenses from sodium selenite injected rat pups showed significantly decreased levels of 
water content compared to that of the control, whereas treatment with NACA 
significantly increased the water content. *p < 0.05 compared to the control group and #p 
< 0.05 compared to the Na2SeO3 group. Values are reported as mean (n=4) ± SD. 




                                     
                              
 
 
Figure 6.11. Effect of NACA on Calcium Levels in Rat Pups injected with Na2SeO3. 
Lens from sodium selenite injected rat pups showed significantly higher calcium levels 
compared to that of the control, whereas treatment with NACA significantly decreased 
the calcium levels. Statistical analysis was performed by one-way analysis of variance, 
followed by Tukey’s multiple comparison tests. *p < 0.05 compared to the control group 



















                         
                                                                        
 
Figure 6.12. Effect of NACA on (A) Casein Zymography, (B) Western Blot, and (C) 
Relative Densitometry Intensities of m-Calpain Protein in Rat Pups injected with 
Na2SeO3. A: Lens from sodium selenite injected rat pups showed a decreased band 
intensity of m-calpain indicating decreased m-calpain activity compared to the control. 
However, treatment with NACA preserved the m-calpain activity; B: Western blot from 
sodium selenite injected rat pups showed a band intensity of m-calpain compared to 
control; C: Western blot results normalized to the levels of Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) protein. The graphs represent relative densitometric analysis of 
treated group lenses over the control group lenses. *p < 0.05 compared to the control 
group and #p < 0.05 compared to the Na2SeO3 group. The graph is representative of 
triplicate gels and the values are reported as mean ± S.E. 
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Figure 6.13. Effects of NACA on SDS-PAGE of Crystallin Proteins. L1 represents 
control, L2 represents NACA, L3 represents Na2SeO3, and L4 represents NACA + 
Na2SeO3 groups. Lens from sodium selenite injected rat pups showed decreased crystallin 
band intensities compared to the control, whereas treatment with NACA preserved the 





Cataract blindness is a major cause of preventive blindness worldwide, especially 
in the developing countries of Africa and Asia [261]. The only effective treatment 
currently available for cataracts is the surgical removal of the opacified lens and 
replacement with an artificial lens to restore sight. Although cataract surgery is 
considered to be a very successful procedure in terms of visual outcome; the cost of 
surgery, need for trained personnel and surgeons, and postsurgical complications, limit 
the worldwide availability and accessibility to this procedure. Hence, alternative 
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prevention and treatment procedures are worthy of investigation [262]. 
Oxidative stress is an imbalance between the rate of oxidant production and its 
degradation [263]. Substantial supporting evidence suggested that ROS and oxidative 
damage were involved in the development of cataracts [264, 265]. Cataract formation has 
multifactorial etiology. Free radical-induced oxidative stress, resulting in the depletion of 
antioxidant defense systems in the lens, is considered to be a major factor in the 
formation of cataracts. The lens depends on a balanced redox state for maintaining its 
transparency, and a high content of GSH in the lens is believed to play a key role in 
achieving this [133, 183, 266], whereas decreased levels of GSH in the lens leads to free 
radical accumulation, resulting in lipid peroxidation and decreased antioxidant enzyme 
activity [193, 194], which all lead to cataract development.  
The sodium selenite cataract model has received a lot of attention as it provides a 
number of general similarities to human cataracts, such as reduced GSH, increased 
calcium, increased lipid peroxidation, decreased water soluble proteins, protein 
insolubilization, precipitation, and proteolysis. Hence, a selenite cataract model is 
considered to be a good model for initial drug trials [247]. Based on this, a number of 
anticataractogenic agents have been tested against sodium selenite-induced cataracts. 
With this background, the present study was focused on investigating the preventive and 
reversal effects of NACA on selenite-induced cataracts.  
Wistar rat pups were injected with sodium selenite on day 10 and the reversal 
effect of NACA on selenite-induced cataract was studied by administering 1% NACA 
eye drops starting from postpartum day 15 until the end of the 9th week. Morphological 




in cataract intensity, when compared to that in the Na2SeO3-only group. But continuation 
of 1% NACA eye drops, until the end of week 9, resulted in a reduction of cataract 
intensity with all of the grade 3 cataracts in the Na2SeO3 + NACA group having reverted 
to grade 2 (Table 6.2). 
A comparative observation of GSH levels, GSSG levels, and the GSH/GSSG ratio 
in the Na2SeO3-only group at week 5 and week 9 showed no significant difference from 
the control group lenses, even in the presence of dense nuclear cataracts. This could be 
because of the regeneration of GSH in the Na2SeO3-only group (Figure 6.2). This can be 
explained by comparing the GR activities between the control group and the Na2SeO3-
only group lenses. GR is an enzyme that catalyzes the conversion of GSSG back to GSH. 
A significant increase in GR activity was seen in the Na2SeO3-only group with relative to 
the control group, indicating the activation of lens defense systems against the oxidative 
stress induced by selenite (Figure 6.6). This could be the reason for increased GSH levels 
in the Na2SeO3-only group. These results are in agreement with previous studies [184, 
267, 268]. According to Wang et al., “the concentration of total lens GSH dropped to 
approximately 25-30% of normal within 12-24 h post-sodium selenite injection, and GSH 
levels recovered completely by 20-25 day post selenite injection, despite the fact that a 
single cataractogenic dose of selenite appeared to be cleared from the lens within 1 
week”. This indicates that a selenite cataract model is not a good model for studies that 
requires longer durations of testing. Interestingly, NACA treatment in the NACA + 
Na2SeO3 group showed a significant increase in the GSH/GSSG ratio at both week 5 and 
week 9, when compared to the Na2SeO3-only group (Figure 6.4). Furthermore, NACA 




week 9, no significant reduction was observed with regard to GSSG levels in comparison 
to that of the Na2SeO3-only group (Figure 6.3). 
Lipid peroxidation is a very important oxidative stress parameter in selenite-
induced cataracts [203, 204, 243].  Lenses from the Na2SeO3-only group showed 
significantly increased levels of MDA at both week 5 and week 9, in comparison to those 
of the control group indicating that, although the GSH levels in the Na2SeO3-only group 
recovered to the control levels, the lipid peroxidation caused by selenite might be an 
important factor contributing to the opacities observed in the Na2SeO3-only group. 
However, NACA treatment in the NACA + Na2SeO3 group have restored the MDA levels 
back to control. The increase in the GSH/GSSG ratio and a decrease in MDA levels with 
NACA treatment in the NACA + Na2SeO3 group support the decreased cataract 
intensities in the NACA + Na2SeO3 group (Figure 6.5). 
 Based on the above results, the experimental design was modified by shortening 
the project to one month. This was done by administering NACA (250 mg/kg body wt.) 
intraperitoneal injections on postpartum days 9, 11, and 13. Selenite (19 µmol/kg body 
wt.) was injected intraperitoneally on postpartum day 10, while NACA eye drops were 
administered starting postpartum day 15 (rat pups opened their eyes on day 15) until 
postpartum day 30. This study was performed to investigate the preventive as well as 
reversal role of NACA on selenite-induced cataracts. Rat lenses from each group were 
examined and photographed on postpartum day 15 when they opened their eyes, and also 
on day 30 before sacrificing the rats to report the cataract intensities. Results from 
morphological observation indicated that NACA was able to prevent, as well as reverse 




As discussed earlier, GSH is the most important antioxidant present in the lens; it 
is the first line of defense against oxidative stress [5]. Results from this study showed a 
significant decrease in GSH levels in the lenses of the Na2SeO3-only group (Figure 
6.8.A) when compared to those of the control group, indicating oxidative stress. In 
addition to a decrease in GSH, increase in intracellular GSSG (Figure 6.8.B) levels were 
observed in the lenses of the Na2SeO3-only group. Furthermore, the ratio of GSH/GSSG, 
which serves as a representative marker of the antioxidative capacity of a cell, decreased 
in the lenses of the Na2SeO3-only. Treatment with NACA significantly increased the 
GSH levels in the NACA treated group. This indicated that NACA had replenished the 
GSH levels and prevented oxidative stress. The protective effects of NACA are probably 
mediated by its ability to supply cysteine for GSH biosynthesis, in addition to reducing 
extracellular cystine to cysteine [191], and by conversion of GSSG to GSH by non-
enzymatic thiol disulfide exchange [24]. These results are in agreement with previous 
studies in animal models which reported a decrease in GSH levels upon Na2SeO3 
treatment [184, 250, 255, 269-272]. 
 However, significant improvement in the GSH/GSSG ratio was not observed in 
the NACA treated sodium selenite group (NACA + Na2SeO3) (Figure 6.8.C). 
Furthermore, changes in the levels of GSH and GSSG were seen to affect the activity of 
the GR. This enzyme plays an important role in GSH homeostasis: it regenerates GSH 
from GSSG. Increased activity of GR in the lenses of the Na2SeO3-only group could be 
attributed to the activation of the lens antioxidant defense network against a change in the 
redox status. However, this increase in activity of GR was not sufficient to convert all of 




ratio. Furthermore, NACA treatment increased the levels of GSH and restored GR 
activity (Table 6.5). 
 Lipid peroxidation has been associated with cataract formation [203, 204, 243]. 
The double bonds in fatty acids undergo lipid peroxidation in the presence of free radicals 
and form stable by-products, such as malondialdehyde (MDA), which are used as 
markers of lipid peroxidation. Lenses from the Na2SeO3-only group had increased levels 
of MDA (Figure 6.9), compared to those of the control group lenses, indicating increased 
lipid peroxidation in the Na2SeO3-only group. These results were in line with other 
studies which have reported increased lipid peroxidation upon treatment with Na2SeO3 
[23, 249, 250, 255, 258, 269, 270]. NACA was able to reduce the lipid peroxidation 
induced by Na2SeO3, by providing adequate amounts of GSH, a substrate for GPx, an 
enzyme that catalyzes the conversion of hydrogen peroxide to water.  
 A key GSH-dependent enzyme, Ttase, catalyzes the conversion of PSSG back to 
PSH, by using GSH as one of the substrates. During cataract formation, oxidative stress 
builds up, due to diminished levels of GSH, and leads to protein-thiol mixed disulfide 
formation. Crystallin-thiol mixed disulfide then precipitates within the lens causing  
cataracts [244]. We speculate that this may be due to decreased Ttase activity as a 
consequence of lowered GSH levels during cataract development. Depletion of Ttase 
activity in cataract formation has been previously reported [168, 245, 246]. Rat pups 
injected with Na2SeO3 showed decreased Ttase enzyme activity, as compared to control, 
leading to the precipitation of crystallin proteins, whereas treatment with NACA restored 





A wide body of evidence indicates the association of cataracts with lens hardness 
[273, 274]. According to Tabandeh et al, lens hardness might be because of the 
dehydration of the lens resulting in increased accumulation of water insoluble proteins at 
the center of the nucleus, leading to compaction of lens fibers [274]. The result from this 
study is in agreement with the above findings. Lenses from the Na2SeO3-only group 
indicated a drop in water content and NACA treatment reversed water levels close to 
those of the control (Figure 6.10). Reduced water content may probably be associated 
with changes in the interaction between protein chains that cause in-solubilization and 
precipitation of proteins, leading to lens hardness. 
 To estimate proteolysis of lens crystallin proteins, SDS-PAGE of the water 
soluble protein fraction was performed. Previous studies have indicated that crystallin 
proteins lie in a molecular weight range of 19-31 kDa, with α-crystallin at approximately 
19-20 kDa, β-crystallin at 23-31 kDa, and γ-crystallin at 21-23 kDa [184]. Intensities of 
the crystallin bands in lenses of the Na2SeO3-only group were significantly lower 
compared to those of the control group, whereas treatment of selenite-challenged rats 
with NACA resulted in considerable preservation of the intensity of the crystallin bands, 
with molecular sizes of around 20 kDa and 23-25 kDa (Figure 6.13). This suggests an 
inhibition of crystallin proteolysis by NACA and, hence, prevention of precipitation. 
 Precipitation of proteins can also result from calcium uptake in the lens. High 
concentrations of calcium in the lens nucleus of selenite cataracts have been previously 
reported by Hightower et al [275], which may have been due to inhibition of Ca-ATPase 
activity [276]. Accumulation of calcium in the nucleus of the lens leads to m-calpain 




Na2SeO3-only group showed a 2.5 fold increase in calcium levels when compared to the 
levels in the control. These results are in agreement with other studies which previously 
reported elevated calcium levels in the lenses of selenite-induced cataracts [169, 184, 
275, 277]. Treatment of selenite-challenged rats with NACA (NACA + Na2SeO3 group) 
prevented such an increase, and maintained the lens calcium levels close to those of 
control (Figure 6.11). 
 Calpains are cysteine proteinases whose activity depends on calcium 
concentrations. Based on the calcium levels required to activate these calpains, two 
predominant forms of calpains have been reported, µ-calpain (micromolar concentrations 
of calcium) and m-calpain (millimolar concentration of calcium) [149]. Increased 
calcium levels lead to dissociation of m-calpain subunits, resulting in activation of m-
calpain that hydrolyzes the lens substrates such as crystallins leading to cataractogenesis. 
However, activation of m-calpain is followed by degradative autolysis of m-calpains 
[253]. In the present study, casein zymography was performed to check m-calpain 
activation. Contrary to the expectations based on increased calcium levels, lenses from 
the Na2SeO3-only group showed decreased m-calpain activity with a less intense band 
(Figure 6.12.A). These results could be attributed to the degradative autolysis of m-
calpain subsequent to their activation. These results were further supported by performing 
Western blots of m-calpain. A similar trend with decreased m-calpain levels were 
observed in the Na2SeO3-only group (Figure 6.12.B and 6.12.C). Decreased m-calpain 
activity and levels can thus be attributed to degradative autolysis following activation of 





 In summary, the data from the selenite study indicated that oxidative stress plays a 
role in cataract formation and, particularly in the GSH system and, therefore, the use of a 
GSH prodrug might prove beneficial in preventing and reversing cataract formation. The 
data supported our hypothesis that NACA protects by increasing GSH, reducing MDA 
levels, and restoring enzyme activities together with the calcium levels. Our present and 
future studies may eventually help ophthalmologists prevent cataract formation in high-
risk populations and non-surgically treat early stage cataracts, producing favorable 






















With establishment of oxidative stress as one of the primary reasons for cataract 
development, the research has shifted towards finding a non-invasive method to alleviate 
oxidative stress that results in cataracts. One logical approach would be through the 
administration of therapeutic doses of antioxidants. In recent years, a significant number 
of studies have reported the positive effects of antioxidants in treating cataracts. NACA, 
is a GSH prodrug and supplies cysteine for de novo synthesis of GSH, in addition it is an 
excellent source of thiol groups and is able to convert GSSG back to GSH by non-
enzymatic thiol disulfide exchange. Furthermore, NACA also supplies cysteine from 
cystine, aiding in intracellular GSH biosynthesis. NACA promotes intracellular 
detoxification by scavenging free radicals and chelating copper ions. The purpose of 
these experiments was to investigate the potential anticataractogenic effects of NACA in 
both in vivo and ex-vivo models. The results described here suggest that NACA provides 
a protective effect against cataracts. 
 In the ex vivo study, Dex was used to induce cataracts and the protective effect of 
NACA was demonstrated against cataracts induced by Dex. Lenses grown in Dex 
medium showed posterior cataracts, whereas the lenses in the NACA treatment (NACA + 
Dex) group showed a decreased intensity of posterior cataracts. The results from 
oxidative stress parameters indicated that NACA was able to reduce the extent of 
oxidative damage by returning the levels back to control. More studies on Dex-induced 




An APAP-induced cataract model was used to demonstrate the protective role of 
NACA in mice. The morphological examination and the results from oxidative stress 
parameters of lenses from each group indicated that NACA was able to prevent the 
formation of dense nuclear cataracts. However, an APAP model was not a direct cataract 
model since it required an inducer such as β-naphthoflavone to activate CYP, which is a 
pre-requisite for cataract development. Therefore, we chose to study the therapeutic 
potential of NACA further in a more appropriate animal model. 
 Sodium selenite-induced cataract model is a reproducible model with many 
similarities to human cataracts and is considered as one of the most favored models to 
perform early drug trials. However, the main drawback with this model is GSH 
regeneration within 25 days post selenite injection, which limits this model to be 
applicable only for studies that require fewer than 30 days of drug trial. The prevention 
and reversal effects of NACA on sodium selenite-induced cataracts can be attributed to 
its ability to increase the levels of GSH and the GSH/GSSG ratio, and decrease the levels 
of MDA and calcium, while restoring enzyme activities. 
The data suggest that NACA has the potential to significantly improve patient 
health and the clinical care of cataracts. Preventing, as well as reversing cataract 
formation, would mean that, in many cases, surgery could be avoided completely. Further 
development of pharmacological agents like NACA may eventually help 
ophthalmologists prevent cataract formation in high-risk populations and non-surgically 
treat early stage cataracts while shifting the emphasis towards pharmacological rather 
than more expensive surgical intervention, producing favorable patient outcomes while 
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